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5EXECUTIVE SUMMARY
The overall aim of this short project is to uncover some of the 
socio-historical roots of antibiotic use in both humans and non-hu-
mans outside of the European and American histories that are now 
well understood. We provide an historical account of the arrival 
and generalisation of use of antibiotics in three Eastern African 
countries: Zimbabwe, Malawi and Uganda. Drawing upon historical 
and ethnographic data, we describe when, how and in what con-
text antibiotics arrived in these countries, providing an account of 
their early uses – both human and non-human. This project follows 
antibiotics as commodities, investigating how they were inserted 
within broader markets and the channels through which they were 
introduced in the African continent.
The project pursues four distinct but interrelated objectives. First, 
to establish when and which antibiotics were first introduced in 
each country of focus. We find that this was not so different from 
Europe: the earliest mentions of antibiotics in Africa date from 
the mid-1940s, and refer to the same antibiotics that were being 
discovered and used in the rest of the world. Second, to investigate 
the context in which antibiotics arrived. We describe this as a set of 
already-functioning healthcare and veterinary systems, which were 
established by the colonial governments and missionary organisa-
tions throughout the first decades of the twentieth century. Third, 
to gain insight into the supply chains through which antibiotics 
were procured and distributed in each country. This was primarily 
through pharmaceutical companies from the UK and the US, which 
saw the market opportunities that drugs (and particularly antibio-
tics) offered in the colonised African territories. Finally, our fourth 
objective is to explore the actors behind the introduction of antibio-
tics, and the interests motivating them. We identify these as colo-
nial governments, medical practitioners (private, colonial officers 
and missionaries) and pharmaceutical companies, who variously 
worked to ease the healthcare burden, and improve productivity 
and profit.
Understanding the arrival and further spread of antibiotics in the 
focus countries can provide important insights about their current 
use. These findings show how antibiotics and biomedicine came 
to be associated together. Considering the interests that brought 
and kept antibiotics in African settings reveals how antibiotics have 
come to exist in the intersection between health, political agendas, 
economic interests, cultural identities and international relations. 
We intend this report to contribute to the development of initiati-
ves to tackle AMR under a One Health framework, expanding the 
scope to include a diachronic perspective on the health of humans, 
animals and the environment. 
6INTRODUCTION
In a time when Antimicrobial Resistance (AMR) is more worrying 
than ever, and when we are grappling with how best to reduce 
our reliance on antibiotic medicines, looking at the past can offer 
insights into alternative paths into the future. The historical deve-
lopment and significance of antibiotics has been reflected in va-
rious excellent works that highlight the social, political and cultural 
embeddedness of these drugs, both in human and non-human 
spheres (Bud, 2007; Kirchhelle, 2020; Santesmases, 2018). So far, 
the focus of these historical accounts and analyses has been most-
ly directed to the presence of antibiotics in Europe and the United 
States, only mentioning tangentially their existence in the rest of 
the world. Concerns about rising antibiotic use in low and midd-
le income countries has led to increased interest in the scale and 
trajectories of antibiotics outside of Europe and the US. As yet, 
there remain numerous gaps in our understanding of antibiotics in 
recent history, especially in Africa. Exploring this history may provi-
de a path beyond fatalistic stories about self-medication, irrational 
use and abuse by African people, and instead understand at the 
contexts and conditions in which antibiotics have been embedded 
in particular locations. 
Historians have indicated the entanglement of antibiotics with bio-
medicine as part of the imperial project. Biomedicine is understood 
to have been considered a necessary replacement for traditional 
African healing practices, as well as offering a philanthropic contri-
bution to the Empire’s civilising mission (Digby & Sweet, 2002; Iliffe, 
1998; Vaughan, 1991). The potency of biomedicine is understood to 
have been achieved in part because of the effectiveness of antibio-
tics in treating infectious diseases. This is understood to have con-
tributed to the consolidation of colonial healthcare systems and, 
more generally, to the adoption of biomedical procedures as a pa-
radigm. However, scholars also intimated that antibiotics enabled 
a different form of biomedicine to travel; that the arrival of antibio-
tics formed as a convenient – if unintentional – replacement for the 
often expensive and sophisticated set of resources, knowledge and 
processes that constituted biomedicine in the West. For example, 
Bud relates that “the power, mass production, and relative cheap-
ness of penicillin had made the drug itself much easier to import 
across the world than the entire structure of Western medicine, 
or even the doctor or Western-style pharmacist” (2007:158). The-
refore, not only can antibiotics be understood to have reinforced 
the biomedical apparatus but in so doing they replaced some of it, 
generating a form of medicine that, while ostensibly the same, was 
somehow different from that practised in the West.
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However, beyond this interesting but patchy picture of the history 
of antibiotics, and their relations to colonial powers, there remains 
a gap in our understanding of when, how and why these medici-
nes were initially used in African countries. Uncovering further the 
histories of antibiotics in particular settings means better unders-
tanding the necessity of antibiotics for biomedicine, the extent to 
which they are entangled with social concepts such as the ‘modern’ 
society, the ‘meshwork’ of political and economic ideologies in 
which antibiotics have been inserted and have potentially co-pro-
duced. 
The present day focus on a One Health framework for AMR has 
now become self-evident, but historically the use of antibiotics in 
humans and animals has been studied separately. Non-human 
use of antibiotics in agriculture is greater, even today, than human 
health-related use. Agricultural use has been directly connected 
with demands for increased productivity of both livestock and 
crops. The use in livestock increased globally during and after the 
Second World War. For colonial settings, this was a period of scar-
city and rationing, with economic pressure on the colonies even 
higher than before. Investigating the role that antibiotics played 
in the post-war economic recovery (during the late 40s and 50s) is 
crucial for filling out the picture of antibiotic use in Africa. Studying 
the uptake and scale up of antibiotics from a historical perspecti-
ve contributes further dimensions to the One Health framework, 
allowing us to understand the diachronic interrelation of human, 
animal and environmental health under particular political, econo-
mic and social regimes. 
INTRODUCTION
8AIMS AND OBJECTIVES
This project focuses on the arrival and generalisation of the use of antibiotics in African 
settings. This project aims to provide a nuanced account of when, how and why antibiotics 
arrived in three different locations: Zimbabwe, Malawi and Uganda. The research and the 
report have been organised around four objectives:
To establish when and which antibiotics were 
first introduced in each country of focus.
Objective 2
Objective 3 Objective 4
To investigate the context into which anti-
biotics were understood to have potential, 
including the interests of colonial and other 
powers in each country of focus.
To gain insight into the supply chains and 
channels through which antibiotics were pro-
cured and distributed in each country.
To explore the actors behind the introduc-
tion of antibiotics, and what it was hoped 
that these substances could achieve.  
The study countries were selected to align with ongoing ethnographic research in each 
country as part of two LSHTM AMR Centre projects: the Antimicrobials In Society (AMIS) and 
Febrile Illness Etiology in a Broad Range of Endemicities (FIEBRE). 
Looking at these three places comparatively allows an appreciation of the differences and 
similarities of their colonial architectures, and how these were reflected in the visions and 
agendas behind each healthcare system. Thus, it is possible to link the particular ways in 
which healthcare was delivered and the colonial interests for each specific territory. Inves-
tigating these particularities is a way of bringing additional nuance to the already-existing 
stories of colonialism.
This project presents exploratory work that considers an overlooked part of the history of 
medicine. Drawing upon archival and historical data, it is an attempt to produce a rigorous 
account of the circumstances surrounding antibiotic arrival in African settings, including the 
different actors involved in this arrival and the interconnectedness created by these drugs. 
Ultimately, this research provides insight into how antibiotics arrived and stayed in Africa, 
aiming to contribute to the development of actions to tackle the problem of AMR under a 
One Health framework. 
Objective 1
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This project has been informed by an anthropological approach to history, following the 
methods of archival ethnography and, to a lesser extent, oral history. To this end, its sour-
ces have included data gathered from archival research, literature reviews of existing histo-
rical accounts and oral interviews with key informants across countries of interest.
The research process for this project began by assessing the material available. In this case, 
the boundary was set in the timeframe from the 40s to the 60s, covering the early decades 
of the discovery and spread of most antibiotics currently known. After this, the next step 
was to collate archives to trace relationships and, after a process of coding, establish the-
matic nodes to compare them. The process of coding ensured the thorough revision of the 
materials, allowing us to find common points and divergences, and, therefore, to re-cons-
truct the processes that took place and so narrate the story in a rigorous way. 
In order to find primary information sources for the present work, an exhaustive search 
of archival materials was carried out using, among other tools, online search engines and 
bibliographic references from academic literature. Specifically, online digital archives and 
physical visits to the British Library provided access to a large number of journals related to 
the topic of this research. Digital materials often allowed the search of key terms, selected 
taking into account both the information required and the topic of the journal: for example, 
pharmaceutical journals offered plenty of information about the composition and proper-
ties of antibiotics as substances, while theme-specific journals about agriculture might 
focus on the practicalities of their use. Likewise, regional or international scopes of these 
journals would entail different displays of information, allowing us to develop a holistic 
perspective of antibiotic use overall and compare it to country-specific particularities. Jour-
nals were selected for their availability and proximity to the focus of this report, and analy-
sed to cover the widest area possible within the temporal, material and thematic limits of 
the research. Hard copies of journals were analysed according to the same criteria through 
a rigorous review of their contents. 
Following this, it was necessary to compare other kinds of materials (books, demographic 
reports etc.), always complemented by bibliographical research regarding the period to 
which the archives referred. It would have been desirable to carry out fieldwork in exis-
ting places and archives, but the COVID-19 pandemic made such travel between countries 
impossible for the lead author, although our findings were able to dovetail with ongoing 
ethnographic work by in-country research teams. It was possible to carry out limited inter-
views through different media, which were pursued with relevant stakeholders in order to 
gain a better perspective about the use of antibiotics in the focus settings during the focus 
period, and to contest the authority of archival evidence as the only source of historical data 
(Stoler, 2002).
The analytical approach of the project has been informed by a postcolonial lens, and a 
particular focus on the ways antibiotics have become infrastructural in material, affective 
and political ways (Chandler, 2019). In the process of analysis, interpretation of materials 
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Objective 1. To establish when and which antibiotics were first 
introduced in each country of focus.
Objective 2.  To investigate the context into which antibiotics 
were understood to have potential, including the interests of 
colonial and other powers in each country of focus.
Objective 3. To gain insight into the supply chains and channels 
through which antibiotics were procured and distributed in 
each country.
• Hospital records, government annual reports, mis-
sionary records, pharmaceutical company records of 
shipping and invoices. 
• Historical accounts of the colonial architecture of these 
locations and, specifically, the colonial health systems.
• Policy briefs, government reports and Development and 
Welfare plans.
• Academic reviews of colonial economy and its relation 
to health systems.
• Independent surveys of disease incidence in African 
settings during the target period.
• International and regional prevention and public-health 
campaigns (WHO, colonial governments).
• Hospital and missionary records. 
• Pharmaceutical, agricultural and medical journals, both 
international and regional, from the focus countries.
• Hospital records, government annual reports, mis-
sionary records, pharmaceutical company records of 
shipping and invoices.
METHODOLOGY
followed questions such as: who created the material being reviewed? With which objective? 
And who was it directed to? The analysis then connected these findings with the broader 
context in which the materials were created (socio-political particularities of the context, 
history, economy, etc.) and the process that led the material to be analysed (where was it 
found, what kind of archive was it, etc.). These processes reduced the risk of taking what 
was written in archival documents as ‘objective’ and contextless, allowing us to situate mate-
rials – as we do when interviewing actors or analysing current policies.
Each of the objectives of this report was explored with particular materials and approaches:
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The findings of the research on these objectives will be addressed in separate 
sections. Therefore, throughout the analysis, as reflected in this report, there 
was a commitment to be aware of the potential for antibiotics to emerge as an 
entanglement between biomedicine and the concept of ‘modernity’. We have 
aimed to consider to what extent the development of the pharmaceutical industry 
is an important factor for the consolidation of colonial healthcare systems and, 
more generally, for the adoption of biomedicine as a global paradigm.
Objective 4. To explore the actors behind the introduction of 
antibiotics, and what it was hoped that these substances could 
achieve.  
• Source companies, brand names and release dates for 
different antibiotics at different periods.
• Trace-backs of suppliers through shipping records, na-
rrative reports, recorded interviews and journal articles 
about antibiotic potentials in these settings. 
• Characterisations of the colonial, missionary and indus-
trial interests and structures in each country.
• Scientific research articles about the non-human, 
non-therapeutic employment of antibiotics in agricultu-
re. 
• Colonial government reports on demands for productivi-
ty within the post-WWII period (1940-50).
• The British Empire’s Development and Welfare plans.
• Timelines of war, colonial powers, missionaries, indepen-
dence, development aid and directions.
METHODOLOGY
12SOURCES AND MATERIALS INCLUDED
This report draws on both primary and secondary sources, as summarised in Figure 1. All 
materials are listed in the bibliography. Among the primary sources, archival materials – 
both online and in hard copy – stand out in providing first-hand information about how 
antibiotics were understood, thought about and represented throughout the period cove-
red by this research. The nature of these archival materials is varied, as it is possible to find 
personal documents (such as memoirs or private letters), official and corporate documents 
(such as reports, official correspondence or adverts) and academic documents, often closely 
linked to the governmental sphere (such as surveys, research articles or journals).
Although primarily academic, journals can 
also fill a broader role as one of the main in-
formation sources for health and agriculture 
professionals in the period considered here. 
The great thematic range that journals cover 
makes them useful tools for historical re-
search of this kind. During the research pro-
cess, we identified different sorts of antibio-
tic mentions within these journals. Among 
these are mentions of antibiotics in research 
articles directly investigating antibiotic uses 
(for the treatment and prevention of disea-
ses, growth promotion, preservation of food, 
etc.), in announcements or news (when a 
new antibiotic is released or available in a 
certain region, when supplies are over, when 
new regulations are implemented, etc.), in 
trade and investment opportunities and ad-
vertisements (among many other drugs and 
chemicals), or in opinion pieces or letters 
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Figure 1: Summary of sources and materials gathered and analysed for this report.
to the director. Each of these ways in which 
antibiotics were mentioned tells a different 
part of the same story; as such, considering 
them together will provide a good perspec-
tive on the complexities of antibiotic arrivals 
in African settings. 
Different sources provide different kinds of 
information, and already-existing historical 
accounts of colonial politics, healthcare, 
economy and agriculture provide an insight 
into colonial African contexts that is essen-
tial for understanding and further analysing 
the arrival of antibiotics. This is why, in this 
report, the sections that refer to the back-
ground of antibiotic use draw largely from 
secondary sources, while specific data about 
antibiotics themselves had to be found in 
primary sources as described above.
13FOCUS COUNTRIES
In this section, we will provide a brief description of the status of 
the three countries in the time period under consideration, relating 
both the specific and shared characteristics between them. This will 
situate the arrival of antibiotics within country contexts. All three 
countries were colonised by the British, but with differing modes, 
interests and implications for systematisation of health care.
European colonists arrived in the country now known as Zimbabwe 
with Cecil Rhodes’ British South Africa Company (BSAC) in 1880. 
Through a concession for mining, the first colony of Fort Salisbury 
was established, which expanded its influence until it was annexed 
to the British Empire in 1923, becoming the self-governing colony 
of Southern Rhodesia (Burroughs, 1999). From then on, up to 1965, 
Southern Rhodesia would follow a system of white minority rule, 
considering the African population as an underclass. Rhodesian 
institutions formed a broad system of segregation aimed at attrac-
ting a greater flow of white settlers and creating a Western-like 
society.
From 1953 to 1964, Southern Rhodesia joined with Northern Rho-
desia (now Zambia) and Nyasaland (now Malawi) to create the 
Federation of Rhodesia and Nyasaland, also referred to as the 
Central Africa Federation. However, although it intended to keep an 
image of unity and solidity, the Federation was never consolidated 
as a single power, and the inequalities between the member na-
tions were patent throughout the period (Keatley, 1963). Southern 
Rhodesia, as the wealthiest and most powerful nation within the 
Federation, kept its autonomy to a large extent, culminating in its 
Unilateral Declaration of Independence after the Federation dis-
solved. The period of existence of the Federation coincided largely 
with the time of major spread of antibiotics, making it a crucial 
timeframe to consider for the purposes of this report. 
ZIMBABWE
14FOCUS COUNTRIES
The colonisation of Malawi was carried out throughout the second 
half of the nineteenth century, with the first settlers being mainly 
missionaries from the Universities Mission to Central Africa (UMCA) 
and other similar missionary organisations such as the Scottish 
Missions of Presbyterian Churches. In 1889, the UK proclaimed the 
British Central Africa Protectorate, ratified in 1891 and renamed in 
1907 as the Nyasaland Protectorate (Burroughs, 1999). 
Nyasaland’s colonial government functioned through the system 
of ‘indirect rule’, which, as opposed to the minority-rule system in 
Southern Rhodesia, was aimed at maintaining the ‘traditional struc-
tures’ of the colonised societies (Burroughs, 1999). The logic behind 
this system was that it would barely require any presence of colonial 
officers on the ground while still forestalling other countries’ claims 
over the land. Therefore, the number of Europeans in Nyasaland 
was much lower than in Southern Rhodesia and the economy remai-
ned rural-based, with little industrial development. As we will see, 
this also affected the development of a proper health system – and, 
therefore, the spread of antibiotics. 
The colonisation of Uganda has certain similarities with Malawi, as 
it was also incorporated into the British Empire as a Protectorate 
following the system of indirect rule. The main difference between 
the two countries was the existence of the Buganda kingdom be-
fore the arrival of Europeans in Uganda, which had a powerful and 
structured government system that remained throughout British 
rule (Roberts, 1963; Wrigley, 1957). The Uganda protectorate was 
established in 1894, after the intervention of the Alliance Imperial 
British East Africa Company (AIBEAC) amidst a number of religious 
struggles within the territory. The AIEBAC gave up its ‘administra-
tive rights’ over the territory and the UK government took over 
through the Colonial Office. This system was maintained until the 
independence of Uganda in 1962.
The presence of missionaries was also relevant for the establish-
ment of the colonial system. Particularly, the missionaries of the 
Church Missionary Society had an important role in healthcare, de-





The findings are arranged in line with the objectives. 
Each section draws on material related to both humans and animals.
A total of 108 archival sources were identified, thematically 
coded and analysed. Materials included articles from 23 
relevant journals reviewed for the period from 1930 to 1970; 
archival research carried out in the United Kingdom National 
Archives and the Uganda National Archives; and materials 
from the Zimbabwe National Archives. A list of the journals 
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To gain insight into the supply chains and 
channels through which antibiotics were 
procured and distributed in each country.
To investigate the context into which antibiotics 
were understood to have potential, including 
the interests of colonial and other powers in 
each country of focus.
To explore the actors behind the introduction 
of antibiotics, and what it was hoped that 





1.1. ANTIBIOTICS FOR HUMANS
1.1.1. Starting point of antibiotics
The results of this analysis are presented in the subsequent sections, subdivided to reflect 
the arrival and spread of antibiotics for humans and the arrival and spread of antibiotics 
for non-human purposes (animal health and agriculture). These spheres are kept separate 
because they are pictured as such within the analysed data; therefore, in order to represent 
how antibiotics were understood during the studied period, we have decided to maintain 
this human–non-human division1.
Although this research is focused on the arrival, uptake and scale up of antibiotics in 
African settings, it is important to situate these substances in relation to their discovery 
and evolution globally. As we have seen, the impact of these substances is never isolated 
in a single territory, but they are part of a wider network of actions and exchanges. The-
refore, we will consider the broad development of antibiotics before moving on to their 
specific uses within the African continent. 
Officially, the antibacterial action of penicillin mould was discovered by Alexander 
Fleming in 1928; nonetheless, humanity had to wait until 1940 to take the first steps 
towards the ‘Antibiotic Era’. In the early ‘40s, Howard Florey and Ernst Chain isolated and 
purified the substance, initiating human trials shortly after (Bud, 2007). It was probably 
the perfect moment for antibiotics to arrive: since the beginning of the century, the ove-
rall importance of pharmaceutical industry had been on the rise – especially in wealthy 
countries of the so-called ‘Global North’. First, people’s trust in the ‘vitamins business’ 
(Bud, 2007) created the infrastructure that pharmaceutical companies needed to keep 
growing, and then the appearance of arsenical compounds (such as Salvarsan and Neo-
salvarsan) set their hopes even higher. Sulphonamides like Prontosil marked the suc-
cessful arrival of antibacterial drugs in the early ‘30s, and the way was paved for the next 
great discovery. The scientific community was filled with enthusiasm: the ‘magic bullet’ to 
get rid of infectious disease was only a matter of time.
Antibiotic development was boosted by the Second World War, when penicillin produc-
tion stopped being an expensive luxury shut away in labs and started to be widely used 
to heal soldiers’ wounds (Santesmases and Gradmann, 2011). The role of US scientists 
in the creation of an efficient and relatively inexpensive method of production put the 
American pharmaceutical industry at the forefront of global antibiotic use and trade. 
However, US leadership was not undisputed: although it was still under the effect of the 
war restrictions, the UK rushed to catch up with their Anglophone allies and competitors 
and soon became a global power in the production and export of the ‘new drugs’.
In 1944, streptomycin appeared as the next step towards a disease-free future, followed 
by ‘natural’ tetracyclines (such as chlortetracycline, 1945 – distinct from the semi-synthe-
tic tetracyclines that started to be produced in the mid-50s) and chloramphenicol (1949). 
1 For current information about the interrelation of human and non-human uses of antibiotics and its effects, see 




For the next decades, more and more antibiotics were discovered, allowing the biomedi-
cal community to dodge problems such as the development of resistance of certain in-
fections or bacterial strains, or the adverse reactions of some patients to the treatments. 
Table 1 shows a number of examples found in primary sources, establishing a broad 






1929 Discovery of penicillin. British Journal of Experimental Pathology (UK)
1943 First use of penicillin as a treatment. Oxford Handbook of Infectious Diseases and Microbiology (UK)
1944 Military use of penicillin in the US and the UK Chemist & Druggist Journal (UK)
1944
- Conference of US Penicillin 
Producers: War Production Board.
- Announce a more efficient way of 
production.
Chemist & Druggist Journal (UK)
1944 First report of Streptomycin Experimental Biology and Medicine (US)
1945 Announcement of coming availability of penicillin for ‘civil use’ in the UK. Chemist & Druggist Journal (UK)
1945
First adverts of penicillin-containing 
products and bases for growing 
penicillin (only for hospital use).
Chemist & Druggist Journal (UK)
1945
Soviet home drug industry: mention of 
antimicrobial development:
- Krustozin (‘Soviet penicillin’)
- Gramicidin
Chemist & Druggist Journal (UK)
1945
Discovery of chlortetracycline (Au-
reomycin) by a team from Lederle 
labs. 
Reviews of Infectious Diseases (US)
1946
First British production of streptomycin 
by Boots Pure Drug Co., Ltd. (first 
batch only for clinical trials). 
Chemist & Druggist Journal (UK)
Table 1. Timeline of antibiotic beginnings globally










- Generalisation of antibiotic use for 
research and treatments. 
- Successful trials to use streptomycin 
for plague and human tuberculosis.
Chemist & Druggist Journal (UK)
British Journal of Pharmacology and Chemo-
therapy (UK)
1948
Consolidation of streptomycin 
as the best treatment for human 
tuberculosis.
British Journal of Pharmacology and Chemo-
therapy (UK)
‘Tubercle’ Journal (UK)
1949 Discovery of chloramphenicol by a team from Parke-Davis (US).
Journal of the American Chemical Society 
(US)
1950 UK production of streptomycin for export (manufactured by Glaxo). Chemist & Druggist Journal (UK)
1950 Use of chloramphenicol for treating whooping cough. Chemist & Druggist Journal (UK)
1950 Antibiotics as the ‘star’ of London Medical exhibition. Chemist & Druggist Journal (UK)
1952
“A decade of penicillin”: Penicillin had 
been available for clinical use in the US 
for 10 years approximately.
American Journal of Public Health (US)
1.1.2. Arrival in Africa
There has been previous interest in the question of the arrival of antibiotics in the African 
continent. Bud (2007), for example, situates the beginnings of antibiotics in Africa around 
the 50s, in relation to the massive anti-yaws campaigns that were implemented by the 
World Health Organisation (WHO) in East Africa. Other historical accounts of health and 
pharmaceutical development – both global (Kirchhelle, 2018) and specific to African 
settings (Dube et al., 2009; Ncube, 2012) – have also loosely mentioned the existence of 
antibiotics in Africa in the middle of the twentieth century. However, a systematic register 
of the timing and the conditions in which antibiotics arrived into different settings re-
mains missing. Their arrival has been roughly connected to colonial healthcare systems 
and missionary enterprises, but a detailed exploration does not appear to have been 
undertaken.
The arrival of antimicrobial drugs in African settings is not easy to situate, given the blu-
rry and complex nature of the delivery of care in these areas – and the interrelation with 
colonial agendas, in a context that lacked fast and reliable means of communication. The 




1.1.3. Early times of antibiotics
3 Most of these branches started in South Africa and, from there, expanded to the rest of the continent. Other specifically Afri-
can pharmaceutical companies were also created (such as Lennon & Co., West African Drug Company Ltd., Electro Chemicals 
Ltd., etc.).
4 See note 2 of this report.
Interestingly, if we compare the dates of mentions of antibiotics in European and African 
settings (as both scientific discoveries and more or less established treatments), we see 
that they were not far apart. In Table 2, we find various examples of early antibiotic use 
within African settings.
and institutional reports and memorandums) reveals the existence of early reports of an-
tibiotic imports and use in the colonised areas of the continent. Indeed, antibiotics seem 
to have been imported to Africa since the very beginnings of their existence, with an 
early focus on medical research. Not much later on, antibiotics went beyond the research 
sphere and became a profitable business, boosting the development of African branches 
of big pharmaceutical companies3.
As we have seen in section 2.1.1., it is important to highlight that when antibiotics were 
discovered and beginning to be used across the world, colonised countries already had 
consolidated health services (M. Gelfand, 1976; Vaughan, 1991). Therefore, there had 
been taking place a  ‘facilitating process’ for antibiotics: as ‘modern’ medicine techniques 
were already playing a role in Africa, with the therapeutic use of sulphonamides among 
them (Brownlee and Kennedy, 1948), local populations and markets were ready to incor-
porate the novelty of the ‘miracle drugs’. As we will discuss in section VI.1., the provision 
of healthcare and the characteristics of this provision responded to the agendas of colo-
nising powers; however, these agendas were varied and often contradictory, shaping in 







Trial of gramicidin and penicillin 
to treat trypanosomiasis in African 
patients that had showed resistance to 
sulphonamides.
British Journal of Pharmacology and 
Chemotherapy (UK)
1944-45
Mention of experimental and military 




1945 Treatment of Rhodesian trypanosomiasis with penicillin.
East African Medical Journal 
(East Africa – various locations)











The Secretary of State for the Colonies 
(Colonel Stanley) confirmed that su-
pplies of penicillin were now available 
from the closest supplier (UK, US, Cana-
da) for civilian use in the colonies.
Department of Supply of Southern 
Rhodesia.
Chemist & Druggist (UK)
1946
Fall in the price of penicillin in South 
Africa – announcement of the creation 
of a ‘bank of penicillin’ in case of 
shortage.
Chemist & Druggist (UK)
1946 Penicillin used for the treatment of relapsing fever in Uganda.
East African Medical Journal 
(East Africa – various locations)
1946
The Secretary of State for the Colonies 
announces that the supply of penicillin 
for the African colonies is satisfactory.
Chemist & Druggist (UK)
1948 Penicillin used for the treatment of me-ningitis in Uganda. The Lancet (UK)
1948
Use of streptomycin and PAS for 
treating tuberculosis in Southern 
Rhodesia.
British Journal of Pharmacology and 
Chemotherapy (UK)
1950 Streptomycin for the treatment of venereal diseases in Southern Rhodesia The Lancet (UK)
1950 Treatment of syphilis in Africans with penicillin
Journal of Venereal Disease Information 
(US)
1950 Aureomycin used for treatment of yaws and ulcer in tropical Africa. Nature (UK)
1950
Campaign for mass administration of 
‘sterilising’ doses of penicillin for the 
treatment of yaws.
Bulletin WHO (International – various 
locations)




Figure 2: Notice about antibiotic supplies for the African colonies 




























Figure 3: Graphic representing the references to antibiotics within 
the revised materials classified by country-cases (based on original 
research data).
So far, we have observed that antibiotics were used in the three focus countries for 
a range of conditions since the 1940s. Next, we must explore how widely they were 
used, in what ways they were used, and for what and whose purposes they were 
put to use. For this, we must consider further questions: what were the agendas 
(political, economic, ideological) that motivated the inclusion of antibiotics in heal-
thcare? What was the availability of medicines on the ground? Who was entitled to 
administer the ‘new drugs’? And, finally, through which channels were these drugs 
brought to these settings and inserted in local markets? 
ANTIBIOTIC ARRIVALS
As we can see here, anti-yaws campaigns 
marked an early use of antibiotics in Africa 
– but not the earliest. Penicillin was used 
to treat African soldiers in the Second 
World War and, later on, antibiotics 
were widely used in research on tropical 
diseases. However, it is important to 
recognise that the global scale on which 
anti-yaws campaigns were implemented 
by the WHO made them a milestone in the 
history of antibiotic spread worldwide.
From the sources reviewed during this 
research, it is possible to infer a degree of 
differentiation in the use of antibiotics in 
the three focus countries. 
As is shown in Figure 3, most references 
to antibiotics concern Southern Rhodesia 
(now Zimbabwe) and, to a lesser extent, 
Uganda. These references are taken 
here to index the scale of use, because 
most references describe, often without 
further specification, disease treatments 
that can be either experimental or 
established. Unsurprisingly, it seems that 
the relative wealth of each setting affects 
the availability of antibiotics, leaving 
barely any mention of antibiotic use in the 
poorer region of Nyasaland (now Malawi). 
From this, we can start to grasp a hint of 
the relation between economic interest, 
colonial powers and antibiotic use.
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1.2. ANTIBIOTICS FOR NON-HUMANS
1.2.1. Beginnings of non-human use globally
Antibiotics were used in animals since the earliest times of their existence; however, 
most historical accounts about them establish a clear separation between antibiotics as 
drugs to preserve human lives and antibiotics as substances given to animals to make 
them grow faster and healthier (Bud, 2007). Therefore, this report reflects this separation 
by the division of human and non-human uses of antibiotics into two different sections.
Non-human antibiotic use has been growing exponentially since the early 1950s, and 
currently forms a quarter of the global total use (Bud, 2007). Non-human use is also 
understood as ‘agricultural’ use, and involves the treatment of animals and, to a lesser 
extent, plants and seeds. We commonly establish two different kinds of use: therapeutic 
and non-therapeutic.
Therapeutic use came first, and is documented since the trials of penicillin in treating 
common animal diseases such as mastitis. One example can be found in the ‘Journal 
of The Royal Agricultural Society of England’, which in 1945 published an article listing 
“diseases of animals”, among which it is possible to find mastitis (‘Diseases of Animals’, 
1945). For treating this disease, the article details the most extended use (at that time) 
of sulphonamides, which only worked partially, alleviating symptoms but not “sterilising” 
the animal against the infection and preventing it from becoming recurrent. To deal with 
this the use of ‘new agents’ is encouraged, “especially the antibiotic penicillin”. The same 
journal displays reports of penicillin becoming more available and widespread among 
farmers throughout the US and Canada.
However, as soon as the possibilities of using antibiotics as enablers for industrialised 
agricultural production were known, the degree of non-therapeutic use grew exponen-
tially (Compassion in World Farming, 2011; Kirchhelle, 2018). Antibiotics can prevent 
infections in crowded animals, reducing the need for space and allowing more efficient 
production; this, added to the uses for accelerating the growth of young animals, sustai-
ned the advance of intensive agriculture (Bud, 2007). And, in turn, the consolidation of 
these farm-factories sustained the diet changes and released labour, opening the way 
for ‘modern society’.
The relation of antibiotics with ‘production’ and market systems goes even further.  
Kirchhelle (2018) has identified certain interwar links connecting US pharmaceutical and 
feedstuff companies: some industrial researchers devised non-human and non-thera-
peutical applications as a profitable new source of income beyond the already-saturated 
human antibiotic market. Hence antibiotic growth promoters (AGPs) – which were  
supposed to also be prophylaxis against bacterial disease – started to be routinely mixed 




And there was more: the use of antibiotics with agricultural purposes kept growing and, 
from the mid-1950s, streptomycin sprays were used for the treatment and prevention 
of plant diseases and tetracycline preservatives were included in the treatment of fish, 
shellfish and poultry (Kirchhelle, 2020). Relatedly, the Food and Agriculture Organisation 
of the United Nations (FAO) also published directions about the use of antibiotics in  
agriculture, mentioning the different uses (especially in fish preservation) that took place 
during the 1950s and ‘60s (FAO, 1961, 1964a, 1964b).
In Europe, antibiotics started being used for individual animals with therapeutic purpo-
ses, but the economic improvements and the arrival of cheaper medicines and AGPs led 
to the quick spread of antibiotic consumption. By the middle of the ‘50s, it was legal to 
use antibiotics without veterinary prescription in all the European territories (Kirchhelle, 
2018). In the specific case of the UK, this spread was not regarded with much optimism 
and the authorities in charge tried to control it – as is proven by the fact that the  
Penicillin Act and the Therapeutic Substances Acts (1947-54) forbade the use of antibio-
tics without prescription regardless of the nature of that use. This hesitancy was a res-
ponse to the already-known threats of antibiotic resistance (AMR) that clashed with the 
demands for increased productivity. The scales finally tipped in favour of the agricultural 
benefits that antibiotic use was bringing, based on the belief that the bacteria causing 
disease in humans and animals were not the same, and that therefore resistance was 
not a major problem (Bud, 2007).
Accordingly, the situation changed in the UK during the mid-1950s when the use of AGPs 
began to be allowed; however, the UK government only allowed farmers to purchase pre-
mixed antibiotic solutions and feeds, instead of buying the pure drugs and mixing them 
themselves. Thus, veterinarians kept more control over antibiotics than their peers in the 
US (Compassion in World Farming, 2011; Kirchhelle, 2020).
According to Kirchhelle, how different sectors incorporated antibiotics in the UK varied 
greatly – they were faster and more widely spread in poultry than in any other livestock, 
for example. Specifically, Kirchhelle says “there is not always a correlation between Euro-
pean intensification and antibiotic use but sinking drug prices and pressure for efficiency 
gradually overcame agricultural hesitancy” (2018). The result was that, in the beginning 
of the 1960s, most of the mixed animal feeds in Europe and the US contained antibiotics.
ANTIBIOTIC ARRIVALS
1.2.1. Beginnings of non-human use globally
When looking into the early non-human uses of antibiotics in African settings, the lands-
cape seems quite different from the human one. In those colonised settings, antibiotics 
were known and used in animals since the beginning of their existence, but their use 
was not as extensive as it was for curing human diseases. Also, unlike in Europe and the 
US, the early African uses of antibiotics in animals seem almost exclusively therapeutic, 
with limited mentions in some African scientific journals of attempts to use them as 
growth promotors – which were not described as overwhelmingly successful.
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A good example of this can be observed in the Annual Report of the Secretary of the 
Ministry of Agriculture in the Federation of Rhodesia and Nyasaland (years 1953-54): in 
this report, the mentions of antibiotics are scarce and slightly hesitant, referring to them 
more as “various new drugs” still being trialled than as medicines by themselves (Minis-
try of Agriculture of the Federation of Rhodesia and Nyasaland, 1953 - 1954). ‘Antibiotics’ 
as a generic term is mentioned as a treatment in a case of calf diphtheria, but it is ac-
companied by a cautionary declaration that “it can only be stated that the animal recove-
red” – as if they were not willing to attribute this to the drug. Penicillin and streptomycin 
are mentioned more explicitly as experimental treatments for fowl coryza; however, the 
sulpha drug ‘Avisol’ is named as the treatment of choice. Similar accounts are found in 
the ‘South African Journal of Agricultural Science’ and the ‘South African Practitioner’, 
where the uses, although slightly more prominent (it is possible to find a few mentions of 
veterinary uses in poultry and cattle during the late 1950s), remain mainly experimental 
and definitely not widespread – as we can observe in Table 3.
An interview with Interviewee #2, a veterinary doctor from Uganda, points to tetracycline 
(with trade names such as Ngombemycine), streptomycin and penicillin as the most used 
drugs in the 1960s – in contrast with now, when people use a wide diversity of drugs with 
ever-changing trade names such as gentamycin, neomycin, etc. The next table describes 






1946 Request for penicillin to be available in British colonies. Chemist & Druggist (UK)
1949
Streptomycin as an effective treatment 
for tomato canker in South Africa. Fur-
ther trials in 1954 and 1960.
South African Journal of Agricultural 
Science (SA)
1951 Successful use of chlortetracycline for mastitis and other veterinary uses. Chemist & Druggist (UK)
1953
Aureomycin for the treatment of the 
Thieileria parva infection in South Africa. 




Use of ‘antibiotics’ (unspecific) 
in a case of calf diphtheria. Fowl 
coryza experiments: penicillin and 
streptomycin. Both in the Federation of 
Rhodesia and Nyasaland.
Annual Report of the Secretary to the 
Federal ministry of agriculture (Federation 
of Rhodesia and Nyasaland)
1958 Use of penicillin in poultry production in South Africa.
South African Journal of Agricultural 
Science (SA)
Table 3: Examples of early non-human uses of antibiotics in African settings.










‘Aurofac’ (chlortetracycline) used in trial 
for growth promotion in pigs in South 
Africa
South African Journal of Agricultural 
Science (SA)
1959 Trial of a series of antibiotics – use as seed protectants in South Africa.
South African Journal of Agricultural 
Science (SA)
1959 Penicillin used for the treatment of mastitis in South Africa. South African Practitioner (SA)
1961
Penicillin, streptomycin, bacitracin, 
terramycin, endomycin, erythromycin, 
thiolutin, oleandomycin, vancomycin & 
novobiocin – study of the absorption of 
antibiotics by soil.
South African Journal of Agricultural 
Science (SA)
5 See note 2 of this report.
Figure 4: Example of antibiotic use in animals. Annual Report of the Secretary to the Ministry of Agriculture 




As we can see, none of the sources reviewed provide evidence of massive use of antibio-
tics from the 1940s to the 1960s. Furthermore, this kind of use remained absent until 
much later in the century. Interviewee #2 revealed that, even though antibiotics seem to 
have been around since the 1960s, the ‘boom’ in their use did not happen until the ‘80s, 
following the dismantling of the colonial veterinary system: “the misuse started after the 
SAPs [Structural Adjustment Programmes] because anybody could now import. The mo-
ment everybody started importing and the pharmacies mushroomed, then the misuse 
started”. 
Indeed, veterinary services were incredibly important for colonial governments. Given 
that productivity and economic growth were a large part of the colonial agenda and the 
rural nature of most colonial settings, the aim of boosting commercial agriculture nee-
ded to be complemented with a functioning veterinary counterpart (Brown and Gilfoyle, 
2010; Hodge, 2007). However, as we will see in more depth further on, the main challen-
ges for settler agriculture could not be solved by using antibiotics; the most pressing 
threat for livestock production were diseases spread by ticks, and these were prevented 
by the movement of stock to different areas (free of ticks) and by livestock ‘dipping’ tanks 
with insecticide solution. The main animal epidemic treated by antibiotics was East Coast 
fever – it is possible to identify some accounts of the use of aureomycin and other su-
ppressive antibiotics for its control (Barnett and Brocklesby, 1966; Giblin, 1990). Yet these 
accounts also mention that antibiotics tended to be regarded as a last resort, with other 
immunization methods being preferred. As this is also a tick-borne disease, ‘dipping’ also 
had an important role in prevention.
The purely commercial side of livestock production was not free of problems itself – the-
re is a consensus in historical literature about the “lack of development of commercial 
livestock production” in the colonies (Schneider et al., 1974; Zeleza, 1985). A number of 
initiatives to promote a Western model of commercial production were implemented, 
but none seem to have been very successful – see, for example, the meat-packing indus-
try that briefly monopolised production in Southern Rhodesia (Phimister, 1978). 
Looking at the accounts of the colonial veterinary system in the same way that we look at 
the health system for humans suggests that the struggle to ‘colonise’ animal production 
was greater than its human counterpart – often, veterinary measures were not easily 
accepted by local populations, and the tension between African pastoralists and farmers 
and Europeans has been widely reported and evidenced (Anderson, 1993; Kalinga, 1993; 
Quam, 1978). It is important to mention the differences existing between the countries 
where African pastoralism dominates (for example, Uganda) and where European far-
mers emigrated in large numbers (for example, Southern Rhodesia) – in the mostly Afri-
can countries the struggle was directed to build a Western-like production system, while 
in places with more white settlers, the main issue were land disputes.
ANTIBIOTIC ARRIVALS
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2. HEALTH CARE CONTEXT
This section summarises the ways in which British colonies organised around human and 
non-human health concerns in the years preceding the advent of antibiotics. The healthcare 
and veterinary systems are described in the context of the different missions and interests 
that guided colonial endeavours in the three countries of interest. Regarding human heal-
thcare, we present the formulations and priorities of the Colonial Medical Service as well 
as missionary healthcare. For the non-human sector, we describe the settings and main 
worries of the colonial veterinary services. This section relies on interpretations from secon-
dary sources as well as primary materials to describe the context in each selected country.
Looking at historical accounts of the early colonial period in the late nineteenth century, 
it becomes evident that in none of the three focus countries did colonial authorities have 
a clear intention of creating an integrated health system for the whole population (M. 
Gelfand, 1976; Hokkanen, 2016; Holden, 2015; Ncube, 2012). Vaughan (1991) describes an 
“impoverished early colonial state” in Nyasaland (now Malawi), which did not provide any 
kind of education or health services except for white minorities. Similar situations were ta-
king place in the rest of East and Central Africa; in Zimbabwe, for, example, from the start 
of the colonisation in 1890 to the mid-1920s, healthcare was not provided at all, as the Bri-
tish South Africa Chartered Company – in charge of the management of the colony at the 
time – did not accept any responsibility for the health of indigenous people (Mutizwa-Man-
giza, 1996). As these examples show, early colonial healthcare was scarce and ad hoc, and, 
up to the 1920s, was focused almost exclusively on maintaining the health of the colonial 
officers and the early settlers – who were not adapted to the rigours of a warm, tropical 
climate. Both Vaughan and Mutizwa-Mangiza relate how the environment was perceived 
as strange, hostile and unhealthy, reinforcing the idea of the need for ‘civilisation’ and the 
virtues of the imperialist enterprise.
However, as Marks and Andersson explain (1988), it soon became clear to the colonial 
powers that the health of European expats was not isolated, but in fact closely connected 
to the health of the native population. Several authors have described how epidemics 
provoked the fear of diseases “knowing no colour bar”, which was the driver of “drastic 
interventions” in several parts of sub-Saharan Africa (Marks and Andersson, 1988; Packard, 
1990). This fear prompted the appearance of some initiatives to manage the health of 
Africans in order to avoid it becoming a threat to Europeans’ health. These initiatives were 
formulated on the assumption that African populations were a ‘reservoir of disease’, a ‘risk 
factor’ that should be either avoided or taken care of (Dube, 2009; Ncube, 2012) – a perva-
sive notion that would persist into the future. 
Consequently, the first public-health initiatives were mostly policies of separation, trying 
to keep the disease ‘contained’ outside the settler sphere. For this, authorities implemen-
ted regulations to segregate housing, food preservation and even washing and laundry 
(Holden, 2015). With the increased migratory movements of native populations in search 
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of jobs, the effectiveness and reach of these segregating initiatives was limited. Holden 
(2015) describes how, in Uganda, the new century brought new notions of development: 
health was not only a matter of fear and survival anymore. A certain sense of responsi-
bility towards African health – added to the growing economic importance of the African 
workforce to colonial economies – brought the systematisation of healthcare to the fore of 
colonial interest. 
Further on, during the first decades of the twentieth century, public-health initiatives in 
Central and East Africa took the form of irregular ‘campaigns’ for the prevention and treat-
ment of diseases. Vaughan describes how these methods, more similar to military ope-
rations than to a healthcare system, considered Africans as a mass, as part of the same 
hostile, unhealthy and dangerous environment that had to be controlled and contained 
(Vaughan, 1991). At that time, colonial health systems were based on prevention and heal-
th education, responding to the need to fight a “pathological environment” and to the mis-
sion to “civilize” and “educate” populations in ‘proper’ and ‘rational’ behaviours (Monnais, 
2009). These beginnings also set the framework in which further public-health initiatives 
would be developed, shaping the Colonial Health Service for Africans as a “native service, 
catering for a non-developed, subject population” (Ncube, 2012) – which would trigger a 
number of problems in the design and implementation of those public-health initiatives. 
Relatedly, colonial health discourses shared a view of ill health as “inherently African” (Ncu-
be, 2012), and so formulated policies and bio-cultural theories based on this perception. 
Despite the recognition of the importance of maintaining the health of Africans, govern-
mental services still took a while to become functional. Missionaries were the first formal 
providers of biomedical healthcare in Malawi, Uganda and Zimbabwe (Doyle et al., 2020; 
Hokkanen, 2016; Pringle, 2019), just as they were in most other African colonies. Missio-
naries also took the lead in training native health staff. Responding to the need for health 
staff, as well as taking part in the ‘civilisation process’, the first native nurses were missio-
nary-trained in 1903 in Sierra Leone.
In Zimbabwe, in common with elsewhere on the continent, missionaries were the only 
providers of education or healthcare for African people up to the 1930s, especially in rural 
areas. However, missionary organisations often faced a lack of resources, which limited 
the range and quality of care they could deliver. Later in the century, during the interwar 
period, the growing demand for healthcare along with the greater incidence of infectious 
diseases and epidemics led missionaries to call upon the government for assistance (Wai-
te, 2000). It was only when the British Colonial Office passed the Public Health Act (1925) 
that the role and obligations of the colonial government were defined (Gelfand, 1953). 
However, as Mutizwa-Mangiza states in her thesis on the medical profession in Zimbabwe 
(1996), the Act focused on the colonial government’s responsibility to tackle infectious 
diseases. Up to the Second World War, the Rhodesian healthcare system developed in a 
“haphazard and uncoordinated manner” due to the lack of expertise and the everchanging 
circumstances (Mutizwa-Mangiza, 1996). Colonial authorities did not put special emphasis 
on the provision of curative services, but rather focused on ‘preventive measures’ such as 
segregation between settlers and native populations, imposition of Western hygienic prac-
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tices and ‘disinfection’ campaigns (through practices such as the spraying of insecticides in 
rural areas). The Native Medical Services grew up as a rudimentary health system consis-
ting of some hospitals for Africans in the urban areas and collaboration with missionaries 
in rural areas (Waite, 2000).
Just as in the example of Zimbabwe, biomedical healthcare in many colonial African set-
tings followed a similar pattern of segregation, Eurocentrism and privilege of the weal-
thiest social groups. The Second World War meant the beginning of greater government 
outlay in African healthcare, as well as a more interventionist policy. This entailed the 
‘secularisation’ of the welfare movement (Vaughan, 1991), which, consequently, involved a 
reduction of the missionary input in health and education.
This was the time when antibiotics appeared in the picture, greatly affecting colonial heal-
th systems – both for humans and non-humans –, but also being inserted in and shaped 
by them. Before getting into the details of antibiotics, in the next sections we will review 
the main characteristics and activities of these health systems, starting with a description 
of the governmental and missionary medical services, and concluding with a review of the 
veterinary service.
HEALTH CARE CONTEXT
2.2. THE COLONIAL MEDICAL SERVICE
The existence of the Colonial Medical Service (CMS) was one of the necessary conditions 
for the arrival of antibiotics in the three focus countries, alongside the work of missiona-
ries in healthcare. In order to accomplish the goals of the imperial project, colonial powers 
had to maintain the health of both settlers and African populations. Antibiotics seemed 
to be the perfect tool for this, as they enabled rapid and effective recovery from diseases, 
keeping a sufficiently ‘healthy’ workforce – that is, keeping populations productive. Howe-
ver, as we will see, this was by no means a straightforward process: economic pressures 
and moral concerns caused a number of tensions and conflicts in the arrival and spread of 
antibiotics. 
On September 4th 1937, the British Medical Journal included a description of ‘The colonial 
medical service’ (CMS), covering all the countries under British rule6. As described there, 
the East African branch of the service included Kenya, Uganda, Tanganyika Territory, Nor-
thern Rhodesia, Nyasaland, Zanzibar, and British Somaliland, and had a “very wide scope 
for clinical work, both medical and surgical, as well as for research and for preventive 
medicine and sanitation”. Indeed, the approach of the East African colonial governments 
to healthcare up to the First World War has been widely characterized as ‘public-health 
oriented’ (Doyle et al., 2020), as it was from the beginning focused on prevention and con-
tainment of disease rather than on curative practice.
6 A more detailed description of the CMS can be found in Appendix 1. 
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This orientation is not unique to the African context, but rather imported from a Western 
context, which considered it a personal responsibility to maintain one’s own welfare (Bud, 
2007; Macfarlane and Worboys, 2008). Health was regarded as a moral duty; therefore, 
illness meant a failure in this duty – and, as we will discuss later on, bringing this ‘superior 
morality’ to colonial settings was one of the main means of legitimisation of the imperial 
project. This increased concerns for white settlers’ health; hence, the governmental atten-
tion to the prevention of infectious diseases was, to a large extent, driven by this ‘morality 
of health’. 
Using Western medicines was considered a true benefit for African societies; this is des-
cribed by Iliffe (1998) who, based on his extensive research regarding the professionalisa-
tion of African doctors from the 1870s to the present day, illustrates this with the words 
of a medical officer who worked in Uganda in 1950: “we share with the rest of the medical 
world the great privilege of treating patients with the newer drugs, especially the sulpho-
namides and penicillin” (1998: 133). However, this was not without consequences, such as 
an increased demand for drugs that often was regarded with concern by colonial medical 
authorities. 
A good example of this can be seen in a circular memorandum from the Medical Depart-
ment of Uganda (1959), which was released to make hospital staff aware of some direc-
tions about “the use and misuse of antibiotics”. This memorandum lists the “main antibio-
tics” that are meant to be used only when it is proven that they are potentially effective 
(that is, when the sensitivity of the pathogen to the antibiotic has been proven, or when 
there have been past positive results). Their use in “desperate situations” is allowed even 
if the diagnosis is in doubt, but they recommend keeping these occasions to a minimum. 
As for the use of particular antibiotics, oral penicillin is considered “an expensive luxury”, 
with injections being the standard form of administration. Penicillin courses are recom-
mended to be kept “short”, with a standard course of five days/shots that can be shorter 
if necessary. Use of penicillin as “prophylaxis” after cold surgical operations is disapproved 
of. Another antibiotic mentioned is streptomycin, whose use is discouraged given that “it 
is far more expensive than penicillin” –use of cheaper alternatives is encouraged when 
possible, for financial reasons. Finally, the broad-spectrum antibiotics “should not be used 
indiscriminately because of their great expense and because suitable alternatives are 
often available”.
We can observe in this example the constant presence of economic concerns within the 
Medical Department. These concerns resulted in measures such as the reduction of anti-
biotic courses and the constant search for the cheapest alternative (which often was not 
the most effective one). And these measures were a major force that shaped the use of 
antibiotics in the African colonies – and, as we will discuss in further sections, it can be 
related to some uses today.
Holden states that “colonial medical services were constantly overburdened and under-re-




rather than on preventive measures” (2015: 73). Another consequence of this was the 
expansion of the reach of the CMS, looking for collaborations beyond the state – formally 
and informally. These collaborations were established with a range of non-governmental 
groups with an interest in the African territories (Greenwood, 2016). And, as we will see 
further on, the role of missionaries stands out among these collaborations.
HEALTH CARE CONTEXT
2.3. MISSIONARY HEALTHCARE
A number of historical accounts about the medical missions in Africa refer to the high level 
of collaboration between missionary doctors and the CMS (Chanaiwa, 1981; Greenwood, 
2016; Hokkanen, 2016; Pringle, 2019). Moreover, delivery of healthcare by missionaries 
often went beyond the scope of the CMS, and was the main provider of medicines within 
rural areas up to the 1930s – and, in some places, up to the 1950s and ‘60s. Therefore, 
missionary organisations played an essential role in the arrival and spread of antibiotics in 
Africa. 
A number of authors have highlighted the importance of missionary work in the three fo-
cus countries (Mutizwa-Mangiza, 1996; Pringle, 2019; Vaughan, 1991) – which, most likely, 
resembles many other British colonial settings on the African continent. This meant that, 
for most Africans, their only contact with Western biomedicine was through missions – 
which gave them an explicitly religious and moralising version of it (Vaughan, 1991).
The nature of missionary work was never well defined, as the ‘missionary’ element was ra-
ther vague (Pringle, 2019). The broad idea was to make the native population more recep-
tive to Christian messages through the ‘amazement’ produced by the effects of Western 
medicine – which meant missions profited from the adoption of the latest therapeutical 
techniques. In this sense, antibiotics were received with enthusiasm, as they had the po-
tential to be another powerful ‘evangelisation tool’.
Undoubtedly, there was a strong religious motivation underlying missionary medical ser-
vices. Healthcare, in its capacity of provoking a ‘sense of wonder’, was meant to create an 
association of the ‘goodness of medicines’ with the ‘goodness of God’. Therefore, medical 
treatment of Africans came to be recognised as an important part of missionary work, and 
one of the ways in which native populations were attracted to the ‘Western way’ (Gelfand, 
1976). Additionally, as Vaughan (1991) points out, long-term healthcare opened up new 
possibilities for conversion – which drove missionary interest in the care of people with 
chronic illness or in need of long-term treatments (such as leprosy, tuberculosis, etc.). The 
long stay in a Christian environment with a constant exposure to religious imagery, rites 
and preaching was supposed to encourage patients towards their conversion to Christiani-
ty. Also, physical transformation was regarded as a direct sign of spiritual transformation – 
thus, the healing of the body was directly related to the healing of the soul. Therefore, the 
arrival of the new effective antimicrobial drugs played a very important role in this con-
sideration, as, on one hand, they boosted the healing rates, but, on the other hand, they 
reduced the treatment times, threatening this long-term conversion strategy. 
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Another important aim of missionary healthcare was in line with the colonial project, in the 
sense that they sought to displace witch-doctors and traditional healers (Doyal and Penne-
ll, 1979; Gelfand, 1976). Antibiotics, being effective treatments for long-dreaded infectious 
diseases, were meant to be the definitive proof of the superiority of the Western system 
of thought, and, by extension, of the superiority of Christian beliefs. For the missionaries, 
the ‘cure of souls’ was not compatible with traditional beliefs, necessarily involving Chris-
tian conversion. Traditional medicine was considered to be ‘witchcraft’ and ‘sorcery’, and so 
uncivilised and evil (Digby and Sweet, 2002) – hence, the role of missionary doctors was to 
convert Africans away from this. Dube (2009) considers this rivalry between traditional and 
Western health providers as a manifestation of the missionary agenda of turning Africans 
into “a new class of individualist westernised Christians operating in the market economy”. 
Biomedicine and, specifically, antibiotics, appear here as a political tool for weakening the 
foundations of traditional society.
We mentioned at the beginning of section 2.3. the close contact that existed between the 
CMS and missions. This contact became a source of collaborations, as missionaries and 
medical officers shared knowledge and, on occasions, resources – among which were an-
tibiotics. However, there were also conflicts and power struggles between them, making 
the relation between missionaries and the CMS complex and changing throughout the 
colonial period. 
When talking about collaborations, the intertwinement between the two organisations 
was such that sometimes the same person was performing a dual role as missionary and 
colonial medical officer, as is described by Pringle (2019). This was possible because, al-
though missionary organisations and the Colonial Medical Service had different agendas, 
they had overlapping interests – as we have seen in previous sections. The mission doc-
tors had developed important skills, such as communication in local languages, and were 
attentive to record keeping. This made them useful for the establishment of colonial 
rule, and they were frequently asked by government officers for advice. Moreover, up to 
the Second World War, their will to take charge of African healthcare meant a welcome 
relief for the small government services – which were, in most African colonies, allocating 
all their energies and resources to maintain the health of government employees or to 
carry out high-profile campaigns against epidemic diseases (Hokkanen, 2016; Iliffe, 1998; 
Messac, 2014). Furthermore, as Hokkanen (2016) says, in Nyasaland the lack of govern-
ment facilities in rural areas meant that, eventually, even government officers and their 
families were relying on missionary healthcare. It is likely that this situation was repeated 
in the rest of the focus countries.
It is also important to pay attention to the informal exchange of medicines and informa-
tion – in Nyasaland, the Medical Department provided some missions with medicines 
during the interwar period (C. M. Good, 2004; Hokkanen, 2006, 2017), and, during most 
of the colonial period, missionaries and their assistants played a crucial role in the imple-
mentation of campaigns against epidemic disease.
2.3.1. Collaboration and tensions between the CMS and missions 
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Medical missions and government services also exchanged knowledge, materials and 
staff in Uganda (Pringle, 2019) and other East African colonies (Crozier, 2007), with simi-
lar dynamics to the ones described for Malawi (frequent, but irregular and circumstantial 
exchanges). However, in spite of these collaborations, both groups still maintained their 
boundaries – and their particular agendas. 
One of the friction points between governments and missions was different diagnoses of 
the root causes of disease in African societies (Vaughan, 1991). While the secular medical 
institutions used a model of ‘collective pathology’ that attributed the prevalence of disea-
se to ‘modern life’ and the ‘disintegration’ of traditional African societies, the missionaries 
placed the focus on individuals. For the missionaries, disease was not a direct conse-
quence of Western ‘civilisation’, but it could only be conquered through the adoption of a 
Christian morality and a sanitised and modern ‘family life’ (Vaughan, 1991). 
Nonetheless, both tensions and collaborations point to the close relation between mis-
sions and the Colonial Medical Service, which was situated within a network of connec-
tions between doctors, patients, administrative staff, materials, medicines, pharmaceu-
ticals, etc. This network was both built and constantly re-shaped by different flows of 
interest, which created the connections and conflicts between health actors. The place 
of antibiotics within this network was, therefore, highly influenced by these interests, 
which, to a great extent, were driven by colonial agendas.
2.4. COUNTRY-SPECIFIC HEALTH CARE CONTEXTS
Up until now, we have explored the formation, history and characteristics of the broader 
health system constructed by both missionary organisations and government medical de-
partments. This is important because, by following the development and particularities of 
the colonial health systems, it is possible to see the political agendas that lay behind them 
and identify certain flows of interest that shaped the environment in which antibiotics arri-
ved – and, indeed, have continued to re-construct it up to the present moment. However, 
antibiotics also filled the role of being vehicles for these flows, facilitating their expression 
and expansion when being traded, used, imagined, planned, disputed, etc.
To achieve a full understanding of how these flows operated, it is crucial to explore how 
they appear within the broader context of the British Empire, and, especially, how they are 
shaped by the different agendas of colonial authorities and other relevant actors. Compa-
ring the three focus countries and the parallelisms and differences that can be established 
between provides depth to the analysis when considering the relationship between colo-
nial agendas and healthcare.
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2.4.1. Malawi
2.4.2. Zimbabwe
First, we can look into the particularities of the health system of Malawi (Nyasaland 
Protectorate during the colonial period). We have already mentioned the relatively small 
scope of Western medicine during the first decades of colonisation, and the great im-
portance of missionary organisations as the main providers of healthcare. This situation 
changed in the 1930s and during the Second World War, when, as described by Messac 
(2014), biomedical services for Africans expanded, becoming more structured and more 
widely available. This expansion responded to the interests of colonial authorities, as the 
generalisation of and free access to Western healthcare would boost the productivity of 
African workers – a healthy workforce being far more profitable than a sick one. It also 
stood to eliminate potential associations of traditional healing practices with local iden-
tities – which threated to incite revolutionary behaviours (Gelfand, 1976) – while, addi-
tionally, bringing the ‘gift’ of biomedicine (considered the best and most efficient way of 
healing people) would justify the colonial objectives of British imperialism, supporting 
their ‘civilisation’ mission.
The expansion of free access to colonial healthcare for Africans in Malawi also coincided 
with early advances in the pharmaceutical industry and with the growing use of chemo-
therapy for the treatment of infectious disease – which meant the possibility of providing 
healthcare without the need for expensive infrastructures, using mainly drugs (Venkat, 
2016). According to Messac (2014), this system continued throughout the colonial period, 
and its footprint reached long after: healthcare fees in Malawi remained some of the 
lowest for most of the twentieth century. 
In contrast with to the case of Malawi, the health system of Zimbabwe (then Southern 
Rhodesia) was clearly designed around the need to cover the white settlers that popu-
lated the country. Even though they were a minority, they constituted an important part 
of the economic system of the country, as they owned the most productive lands, which 
made this group an important lobby group and point of interest for the colonial govern-
ment (Chanaiwa, 1981; Duggan, 1980; Mutizwa-Mangiza, 1996). 
Moreover, as Southern Rhodesia was a self-governed colony, their aim was to attract 
more white settlers who would reinforce the power of the white minority, rendering the 
colony more like a Western-like setting. With this aim, hospitals for Europeans were mo-
dern and expensive, designed to resemble the ones found in European contexts (Good, 
1974; Mlambo, 1998). Consequently, as we have seen, practically the only healthcare 
available for Africans was delivered by missionary doctors, especially in the case of rural 
or more inaccessible areas (Gelfand, 1976; Ncube, 2012).
It is important to note here that the situation in these two countries shifted slightly when 
the Federation of Rhodesia and Nyasaland was created. The political union of both  
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territories was an attempt to increase economic and political growth, and to face the so-
cial changes within the territories by ‘uniting forces’ (Gear, 1960; Keatley, 1963). Thus, the 
appearance of the federation caused an alignment of the two countries’ interests, to the 
extent that the medical services and other ‘health’ matters started to be a prerogative 
of the Federation. However, this apparently harmonic union did not last long, and it was 
always possible to find inner differences of decision-making power. Southern Rhodesia, 
as the wealthiest region, had more weight in the Federation than the other two coun-
tries, and maintained autonomy in many political and administrative decisions.
2.4.3. Uganda
As Uganda was also a Protectorate, the healthcare situation was similar to the one in 
Malawi (Holden, 2015; White, 1995) – with the difference of the pre-existence of the King-
dom of Buganda, which allowed a more efficient application of indirect rule (Roberts, 
1963). Again, we find in Uganda a small, unorganised medical service that depended to a 
large extent on the activities of missionary doctors.
The main healthcare worries for the Ugandan colonial government were concerned with 
migrant labour as it became an important part of the workforce, which is reflected in the 
Annual Reports of the Medical Department (Uganda Medical Department, 1945-1951). In 
1948, the Department warned about the increasing incidence of disease among African 
migrants and urged the government to act. The reasons outlined range from the “hu-
manitarian point of view” to explicit concerns about how “the immigrant’s productivity 
as a labourer is lowered”, and about how “it is bound to harm the indigenous population 
directly and indirectly”. 
Looking at these examples, it becomes clear how colonial interests shaped the different 




It was not only human health that was shaped by the interests of colonial powers: com-
mercial agriculture was also an important asset for the British Empire, and this became a 
point of major interest and concern in the colonisation of Africa. However, the expansion 
of trade that was carried out to reach these colonial goals had an unwanted side effect, 
disseminating Old-World pathogens to the newly incorporated territories and causing 
major epizootics during the second half of the nineteenth and first decades of the twentie-
th centuries (Brown and Gilfoyle, 2010). Diseases like rinderpest became a major problem, 
requiring a fast and efficient solution and leading to the creation of colonial veterinary 
services – and the allocation of a large amount of funds to the matter, as is demonstrated 
by the announcement that Mr. James Griffiths (Secretary of State for the Colonies) made in 
1950 of the issue of £146,865 from the Colonial Development Welfare Research Funds for 
veterinary projects to assist in the coming African cattle diseases.
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A good example of colonial veterinary systems – and how they were shaped by these fears 
and interests – is described by Figuié, Binot and Caron (2015), who analyse the interven-
tionist policy that the colonial government adopted in Southern Rhodesia. The Rhodesian 
Veterinary Service was created in 1896 under the authority of Elias Grey (its first head) and, 
in the same year, the ‘Animal Disease Act’ was passed to give power to the Service to qua-
rantine or cull sick animals. This “authoritarian colonial veterinary regime” implemented 
preventive measures (such as compulsory vaccination of imported animals, which were 
more susceptible to disease), which culminated in the 1930s with the ‘Land Apportionment 
Act’ of 1931 that gave absolute power to the Veterinary Service to control animal growing 
and production in the country following the foot and mouth disease epizootic (Figuié et 
al., 2015).
The case of the Ugandan Veterinary service is also useful in illustrating the role of antibio-
tics and their insertion and use within the system. To achieve a better understanding of 
the functioning of this service we can refer to the interview carried out with Interviewee 
#2, a Ugandan veterinary doctor who carried out his work starting in the late 1950s. 
Uganda’s Veterinary Service was reinforced in the ‘50s following a serious epidemic of 
rinderpest that obliged colonial authorities to strengthen their control of vaccinations 
and surveillance, and they started to widely train local people as veterinary staff. As Inter-
viewee #2 remembers it, by the year 1956, a good-quality veterinary service was already 
running in Uganda.
During the late years of colonial rule (around the ‘50s and ‘60s), Uganda, like several other 
British domains in Africa, was trying to improve its economy by raising its productivity 
(Bolt and Green, 2015; Quam, 1978). A system was created in which the so-called ‘pro-
gressive farmers’ were encouraged to move out of subsistence to commercial production 
(a similar program was implemented in Nyasaland, called the ‘Master Farmer’s Scheme’ 
(Kalinga, 1993)). This program provided these farmers with subventions and grants in 
order to help, for example, those wanting to fence off their farms, develop better pastures 
or control ticks (Bowden and Moris, 1969; Carswell, 2002). Among these aids, an amount 
of imported goods was provided to the farmers, and these included drugs – however, they 
were not allowed to use the drugs themselves, being instead obliged to report to the Vete-
rinary Office. 
The Colonial Veterinary Office, according to Interviewee #2, included professional vete-
rinary officers, diploma-holding animal husbandry officers and certified veterinary assis-
tants – complemented on the ground by ‘field assistants’ (also called ‘veterinary scouts’), 
who held a specific surveillance role. Therefore, all the supplies of drugs were tightly 
controlled by the government, who regulated and restricted their use.
It was after independence, when the Structural Adjustment Programmes came into force 
in 1993, that the private sector took over this strictly controlled system and the trade and 




2.5.1. Key concerns of the colonial veterinary service
We have already established the crucial importance of the veterinary system for the co-
lonial authorities during and after the colonisation process. However, as we have men-
tioned, antibiotics do not seem to have constituted a great part of this system until much 
after African countries became independent. This can be attributed to the conjunction 
of multiple factors, such as the economic constraints that the colonies were constantly 
facing (which obliged them to prioritise and figure out the most efficient ways of using 
resources) and, as the scientific literature of that time shows, the nature of the major 
veterinary threats (for which antibiotics were not so useful).
The main worries for farmers and veterinarians in colonial Africa were related to the 
insertion of new breeds and farming techniques into a foreign environment, which often 
caused a disruption of the ecological balance and, therefore, prompted the appearance 
of epizootic diseases with dramatic consequences (Anderson, 1993). These problems 
were not unknown by the colonial authorities, as is shown by the records of the Annual 
Conferences of the Professional Officers of the Department of Research and Specia-
list Services that was organised by the Federal Ministry of Agriculture of Rhodesia and 
Nyasaland (Federal Ministry of Agriculture, 1956, 1960, 1963). In these conferences, the 
difficulty of carrying on with Western ways of farming and land use in those latitudes is 
acknowledged, to the extent of considering research into “native agricultural ways”. No-
netheless, discussions always seem to have concluded in favour of keeping trying with 
‘modern’ techniques that, ultimately, would ensure the production and efficiency of the 
system.
These conferences also echo the key concerns that are depicted and analysed in scienti-
fic journals and papers of the time, all of them related to the climate and the soil: erosion 
and uncontrolled floods that affect crops, leading to malnourished livestock and the 
propagation of tick-borne diseases. As a consequence, the use of antibiotics made little 
sense under these circumstances, and chemicals like fertilisers, insecticides, protein/nu-
tritional supplements, etc. were prioritised instead.
When observing concerns about disease at this time, we see that most major epizootics 
had a parasitic or protozoic origin. During 1956, Dr. LeRoux travelled through the territo-
ries of the Federation investigating animal parasitism and the effects that it may had in 
the livestock industry there (Leroux, 1957). He identified a high number of helminths and 
made recommendations to the government for their treatment and control – focusing on 




In the literature available about this topic (Brown and Gilfoyle, 2010; Figuié et al., 2015; 
Steele, 1981), three diseases stand out as most problematic:
• Animal trypanosomiasis: a protozoic disease transmitted by ticks, usually preven-
ted by the use of insecticide ‘dipping’.
• Rinderpest: an infectious viral disease affecting mostly cattle, usually controlled 
by quarantines.
• East coast fever: another protozoan parasitic disease, often transmitted by ticks; 
even though there is some evidence of antibiotic use to treat it (Neitz, 1953), 
other control methods such as insecticide ‘dipping’ are generally preferred. 
As we can observe, the main control technique was based on the use of insecticide and 
‘dipping tanks’ for cattle – while the importance of antibiotics is secondary, being used 
only rarely. In the interview carried out with Interviewee #2, the vet from Uganda, he 
talked about how there were some attempts to treat rinderpest with antibiotics, but the 
colonial government did not allow it based on the inefficacy of the drugs to fight a viral 
disease: “when an animal is sick [with rinderpest], it dies. Animals infected with tick-bor-
ne diseases may die or cure, if you treat them with antibiotics they may cure, but if it was 
rinderpest, we had to automatically kill them. At that time, antibiotics were in the hands 
of government officials who obeyed the procedure”. 
The other great worry was soil erosion. According to Duggan (1980), almost all the go-
vernment expenditure in the 1940s and most of the 1950s was on basic soil to maintain 
the fertility of the land. Maintaining soil fertility was the only way to provide proper 
standards of living and nutrition, so colonial ministries of agriculture put a great deal of 
effort into that (Hodge, 2007).
Veterinary and soil scientists attributed the issue of erosion to overgrazing, so they pus-
hed for measures to control it. These measures were based on controlling the grazing 
of the herds and limiting the number of animals, forcing African farmers to reduce their 
herds – which made these measures unpopular and caused tensions between govern-
ments and farmers. The most immediate reaction to the difficulties caused by land de-
gradation was the insertion of new inorganic and mechanical techniques of cultivation, 
such as the use of artificial fertilisers, mechanic ploughing and other methods that entai-
led radical changes in local farming systems (Hodge, 2007). However, these methods did 
not make a significant impression on local farmers, and the strain of land degradation 
kept growing alongside rapid population growth and the abandonment of the rural envi-
ronment through urban migration.
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The role of colonial governments was undoubtedly crucial in the arrival of antibiotics. Very 
early on, the ‘Chemist and Druggist’ journal (‘Penicillin for African Colonies’, 1945)7 men-
tions the Department of Supply of the different African colonies as the institution that takes 
care of the provisions of commodities (antibiotics among them). Another article explains 
to young entrepreneurs how to ‘pioneer in East Africa’ as a pharmacist by being employed 
in the British Government’s scheme for the production of groundnuts in East and Central 
Africa – revealing the role of pharmacists also within the government medical services. In 
July of 1946, this journal also talks about the concession of licenses for exporting penicillin 
to the British Colonies.
Hokkannen (2017) describes how in the late 1920s and early 1930s, the Nyasaland govern-
ment took the initiative of selling drugs ‘at landed cost price’ (without freight costs in their 
arrival at the coast) to support the medical provision that large employers were offering to 
their employees. This ‘aid’ was beneficial for the government’s own interests, ensuring that 
it would remain the major supplier of medicines to European employers operating in Nya-
saland. This provoked criticism from the Nyasaland Pharmacies Company, who considered 
it an example of ‘unfair competition’, as this policy made the purchase of drugs from the 
government more appealing.
A similar tension appeared between the Colonial Office and the Proprietary Remedies Ex-
port Group in 1947 (‘Proprietary Remedies Export Group’, 1947), as the Colonial Office advi-
sed the import control authorities in the Colonies to refuse to grant import licenses for Bri-
tish goods. As the absolute majority of Western drugs used in the colonies were purchased 
from British suppliers (Hokkanen, 2017), the companies forming the Proprietary Remedies 
Export Group suffered losses because of colonial buyers turning to other sources of supply. 
Indeed, the beginnings of pharmaceutical companies in colonial Africa were closely 
linked to their ability to import from the UK and the US, and so they were gathered in the 
wealthiest spots – most drug companies that established branches in Africa were settled 
in South Africa or, to a lesser extent, in Southern Rhodesia. Since the very beginning, 
many large pharmaceutical companies opened specifically African branches, which often 
still exist today – in Figures 5 and 6 we can see some images of logos of companies that 
had branches in Rhodesia, Nyasaland or Uganda. One good example of this is the case 
of Glaxo (now GSK), which opened its first African branch in Kenya in 1930 and now has 
extended its coverage over the whole continent. We can see more about this in Table 4, 
which reproduces an extract from the book Making Medicines in Africa written by Banda et al. 
(2016)
So far we have documented and contextualised the first appearances of antibiotics in 
African colonies. We now turn to the channels through which they arrived, and where 
they were coming from.
7 See Figure 2.
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Table 4: Fragment of the table of selected pharmaceutical 
companies with a presence in African countries (Banda et al., 2016).
In the table, we can also observe how, 
after some years, a few factories for the 
manufacture of antibiotics were opened 
– for example, CAPS Pharmaceuticals 
opened its doors in Zimbabwe during 
the 1960s. However, the great majority of 
antibiotics used in most African countries 




As we advanced above, in the period that this report is covering, the 
vast majority of antibiotics were imported from the UK and the US. 
These imports increased greatly over time, with the early addition of 
South African influences. There is strong evidence of American exports 
of chemicals – and, among them, antibiotics – to the British African 
colonies, particularly to the Federation of Rhodesia and Nyasaland, but 
also to Uganda. In Table 5, we can see a relation of these exports in the 
period around the 1950s and ‘60s - which we can compare with Table 6, 
showing the antibiotic imports of the Federation overall.
Figure 5: Example of pharmaceutical company with presence in 
Africa (Chemist and Druggist, 1950).
Figure 6: Example of pharmaceutical company with presence in 
Africa (Chemist and Druggist, 1953).t
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Table 6: Fragment of a list of the total drug imports of the Federation 
of Rhodesia and Nyasaland, including antibiotics (Weeks and Macy, 1956)
SUPPLY CHAINS
Table 5: Fragment of a list of American exports to the Federation 
of Rhodesia and Nyasaland, including antibiotics (Weeks and Macy, 1956)
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4. ACTORS AND INTERESTS
4.1. Who could administer antibiotics?
Around 1945, mass production of penicillin started after the war scarcity. South Africa 
experienced a fall in the price of penicillin, creating a ‘bank of penicillin’ in defence against 
possible future shortages – a situation not well received by the United Kingdom, who 
accused South Africa of using ‘too much’ penicillin (‘Penicillin in South Africa’, 1946). The 
control of antibiotic use in each country responded to similar logics: the UK itself released 
the ‘Penicillin Act’ in 1947, safeguarding the governmental prerogative of deciding who 
could use and prescribe the ‘new drug’ (Bud, 2007). In 1951, aureomycin and chloram-
phenicol were also brought within the scope of this act, which made them only available 
under prescription of health centres approved by the Ministry of Health. 
In the colonies, the situation was far from so controlled, but some attempts were made to 
meet the standards – as shown by the ‘Pharmacy, Poisons and Dangerous Drugs Act’ that 
was established in Southern Rhodesia in 1952 (‘Medical Council of Southern Rhodesia’, 
1955). Three years later, the Federation of Rhodesia and Nyasaland tried to establish a 
Medical Council in the Federation, similar to the one existing in Southern Rhodesia, since 
they considered that the separation of legislation was not providing ‘satisfactory results’ – 
however, this initiative never went through. 
Another point of struggle involved private practitioners and their role in the delivery of 
healthcare in the colonies. In contrast to missionaries, private doctors mostly cared about 
white settlers, being driven by the aim of profit and business – to which end antibiotics 
helped a great deal (Bud, 2005). The governments agreed with this situation as long as 
it meant a reduction of the healthcare burden for themselves. However, problems were 
frequent – for example, in 1956 the Federal Assembly (of the Federation of Rhodesia and 
Nyasaland) complained about the government officers coming to the private practice in 
order to profit, charging fees to their patients while receiving government funding (‘In the 
Federal Assembly’, 1956). The competition of private doctors with other medical workers 
has also been described by Iliffe (1998), who traces the complaints of ex-public service 
workers who were not allowed to dedicate themselves to private practice until the late 
1980s.
Previously in this report, we talked about colonial governments’ 
efforts to control medical practice through the imposition of a re-
gister of medical practitioners. The Colonial Medical Service con-
trolled medical appointments in the self-governing colonies, such 
as Southern Rhodesia, and other territories under British control; 
positions were not in general open to candidates from the United 
Kingdom (‘Registration Of Foreign Practitioners In Great Britain 
And The Dominions And Colonies’, 1937). In the remaining terri-
tories that fell under the administrative direction of the Colonial 
Office, the appointments were made by the Secretary of State for 
the Colonies in that country. 
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4.2. Tensions between medical practitioners and pharmaceuticals
Among the power struggles that arose in relation to antibiotic use, probably the main one 
was that between pharmacy workers and medical practitioners. The rise of a strong and 
effective pharmaceutical industry in the UK meant the increasing reliance of people on 
medicines as a way of maintaining their health (Bud, 2007). 
But, as we have already mentioned, the spectre of resistance made concerns about overu-
se increasingly audible, leading to government restrictions on the sale and production of 
antibiotics in the UK. However, these restrictions became lighter under the pressure of a 
pharmaceutical industry that claimed not to be able to invest in the discovery of new anti-
biotics unless they were able to make a profit from their production.
This struggle to sell antibiotics over the counter was reproduced in our African focus 
countries and continues up to the present day (Bud, 2007; Iliffe, 1998). A correspondence 
exchange between the Chief Pharmacist of Kagardi Hospital (Uganda) and the Medical 
Superintendent as late as 1972 (Mapusl, 1972) can serve as a good example of these ten-
sions between pharmaceuticals and medical practitioners. In this exchange, the Super-
intendent urges the Chief Pharmacist to take measures regarding the failures of a drug 
dispensary in distributing antibiotics – apparently, the drugs were not reaching the in- and 
out-patients as they should have been. The instructions are to stop the activities of the dis-
pensary until further notice – orders that the Pharmacist rejects in a further letter, making 
reference to a previous letter that allowed them to dispense ‘minor antibiotics’. This cut 
and thrust points to the long-lasting struggle about who had the right of providing anti-
biotics to the general public, and how. 
Talking about the patterns of penicillin use in the UK, Bud follows “the radical shifts in 
patients’ attitudes to doctors that took place during the years after the Second World War” 
(2007:140). Around the 1950s and ‘60s, Bud describes a fall of trust in doctors: the acce-
lerated ‘pace’ of living drove patients to demand drugs to get a ‘quick fix’ of their health 
problems, similar to what authors have noted in East Africa today (Denyer, Willis and 
Chandler, 2019). Although this situation was convenient for the more and more overwhel-
med doctors, there started to be claims that regarded this situation as a deterioration of 
their service, advocating for going back to a model of healthcare that allowed doctors to 
build a relationship with their patients. As we can see from comparison with today’s world, 
this patient-doctor relationship was never the same following the inclusion of the figure of 
the pharmaceutical (Macfarlane and Worboys, 2008), which established an interconnection 
covering patients, doctors, insurance bodies, pharmaceutical companies and the state.
These tensions around the administration of antibiotics were also taking place in African 
settings. There started to be a generalised feeling that patients needing modern drugs 
did not necessarily need doctors. Iliffe makes reference to this fact by pointing out that “as 
Trowell told the Frazer Committee in 1955, between 30 and 60 per cent of those attending 
Mulago Hospital could have treated themselves with drugs bought at a pharmacy” (1998: 




the obvious expansion of attendances in medical units (due to the ease and availability 
of effective treatments) – it also made the availability of drugs a central point of criticism 
of the medical system (meaning that a ‘good’ health system was defined by the disposal 
of medicines) and bred frustration among doctors if they could not provide their patients 
with the necessary drugs. 
The combination of the lack of resources with the perception of a decreasing need for 
professional doctors to use chemotherapy boosted the presence of antibiotics in the infor-
mal sphere. Many authors have made reference to this phenomenon – see, for example, 
Holden (2015), who describes how the black-market trade and theft of medical equipment 
were perennial problems for the colonial healthcare of Uganda, speaking about the “many 
accounts of the orderly that set up a centre outside of the hospital offering injections gi-
ven with a blunt safety pin”. 
This phenomenon was also described by Iliffe, who talks about the figure of the ‘needle 
man’ in the Bunyole area of Uganda, a “retired tribal dresser or totally untrained practitio-
ner with a syringe and some stolen phials of penicillin” (1998: 134). He also mentions the 
‘bush doctor’ – who is described as a former health worker of lower range than a doctor 
“who has acquired needles and syringes illegally and some antibiotics and chloroquine. [… 
He] tries to combine both traditional and western medicine in his practice often with tragic 
results” (1998: 190). According to Iliffe, it was not unexpected to find former nurses and 
paramedics with less training than a doctor opening small illegal clinics or, more simply, 
selling drugs and injections from their own houses. 
Wilcox (1949) saw this as a problem in the context of Southern Rhodesia, considering na-
tive medicines and extra-hospital treatments as ‘risk factors’ for the treatment of venereal 
diseases. In particular, he described the ‘sophisticated’ methods of the ex-medical order-
lies who became ‘native herbalists’ and gave stolen drugs or useless injections to their 
patients. 
This phenomenon was rooted in the interaction between the growth of chemotherapy 
and the weakening of the colonial state: the governmental ordinances that restricted drug 
administration and sale to anyone but authorised professionals were losing their power, 
opening the way for the rise of self-medication. Iliffe relates how “by the 1950s the repres-
sion of needle men and drug sellers was increasingly difficult, as can be seen from amend-
ments to the law” (1998: 134). However, Willcox was optimistic about the possibilities of 
bringing people to the ‘right path’, stating that “when adequate, free, rapid and, if desired 
by the patient, out-patient treatment is given by both the government and the municipal 
clinics, the popularity of these persons [illegal practitioners] should gradually decline, pro-
vided that a proper check is kept to see that the penicillin is not being misappropriated” 
(1949).




What Willcox did not take into account is that this rise of self-medication went beyond the 
pure accessibility of medicines, and was more like a change of mindset. This can be ob-
served in the fact that it was not limited to Western drugs: it also extended to indigenous 
medicine (Iliffe, 1998). The simplicity, convenience and privacy of chemotherapy became 
more and more appealing amid religious diversity and augmented spatial mobility, ma-
king clear that “behind the triumph of self-medication lay not only the power of pharma-
ceutical companies but a larger process of social change” (1998: 135).
When talking about colonial medicine it is important not to forget that, for many Africans, 
Western healthcare was either not well known or not easily accessible. Vaughan reminds 
us that “for most, mission and government hospitals were peripheral agents of health-
care” (1991: 33). Talking about Malawi, Vaughan stated that until well beyond the middle 
of the twentieth century there was not a high number of dispensaries, so African families 
did not fully engage with Western medicine – and, when they did, it was often in their own 
terms, following their own expectations and priorities. Similarly, Pringle points out that in 
Uganda, although the expansive reach of Western medicine is undeniable, it remained on 
the periphery of a larger therapeutic landscape (Pringle, 2019).
Talking about patients in Uganda, Orley 
notes that they “looked for a system that 
worked, and if one traditional remedy failed 
then another could be tried and so on until 
eventually Western medical treatment could 
also be given its chance” (Orley, 1970; seen 
in Vaughan, 1991: 33). And, additionally, this 
happened also in the opposite direction: 
some African peoples tended to assimilate 
some aspects of Western medicine into their 
own healing systems (Vaughan, 1991) – a 
fact that clashed with the tight control that 
medical departments and missionaries wan-
ted to exert over medical practice. Indeed, 
the medical and pharmaceutical authorities 
of the time looked at these unorthodox uses 
of medicines with a mix of amusement and 
disapproval – in Figure 7 we can see a brief 
article about the “odd uses” of well-known 
medical commodities by African people.
We have already mentioned the role that  
colonial authorities wanted African health 
staff to fulfil – as agents of displacement 
of traditional healing practices in favour of 
Western biomedicine. This is rooted in the 
belief that African health workers would be Figure 7: Example of colonial perspective on the African use of 
antibiotics (Chemist and Druggist, 1949).
ACTORS AND INTERESTS
compelled by the superiority of Western 
medicine over indigenous healing techni-
ques, which would drag them away from 
their traditional background to spread 
the goodness of colonial healthcare (Di-
gby and Sweet, 2002). However, colonial 
officers did not adequately recognise 
the resilience of traditional beliefs or the 
convenience that having a choice between 
medical systems could represent for the 
native peoples. These factors gave rise to 
a certain kind of medical pluralism that 
has survived up to today.
Discussion
49DISCUSSION
Throughout this project we have pursued four distinct but inte-
rrelated objectives. First, to establish when and which antibiotics 
were first introduced in each country of focus. We find that this was 
not so different from Europe: the earliest mentions of antibiotics 
in Africa date from the mid-1940s, and refer to the same antibio-
tics that were being discovered and used in the rest of the world. 
Second, to investigate the context in which antibiotics arrived. We 
describe this as a set of already-functioning healthcare and veteri-
nary systems, which were established by the colonial governments 
and missionary organisations throughout the first decades of the 
twentieth century. Third, to gain insight into the supply chains 
through which antibiotics were procured and distributed in each 
country. This was primarily through pharmaceutical companies 
from the UK and the US, which saw the market opportunities that 
drugs (and particularly antibiotics) offered in the colonised Afri-
can territories. Finally, our fourth objective is to explore the actors 
behind the introduction of antibiotics, and the interests motivating 
them. We identify these as colonial governments, medical practi-
tioners (private, colonial officers and missionaries) and pharma-
ceutical companies, who variously worked to ease the healthcare 
burden, and improve productivity and profit.
In this discussion section, we will discuss the findings of 
the arrivals, incorporation and distribution of antibiotics 
through three themes. First, by looking at the different 
colonial agendas, we link their interests to the presence of 
antibiotics. Second, we look at the ways that antibiotics shored 
up economy and productivity, both for humans and animals. 
And third, we look at antibiotics as commodities, escaping the 
structures of previous health care schemas.
50
Colonial agendas and antibiotics
Colonial agendas and antibiotics
Throughout this report, we have looked into the agendas of the main actors in colonial 
healthcare – missionary organisations, the Veterinary Service and the Colonial Medical Ser-
vice – and related them to the particular contexts in which they were inserted. Now, we will 
briefly look at the political agendas that can be identified by analysing the ways in which 
antibiotics were used in colonial contexts.
For the successful development and maintenance of the colonial project, it was crucial to 
keep social and civic order. To this end, antibiotics were used to move African people away 
from traditional healing practices and cultural beliefs that were threatening colonisation 
– as happened, for example, in Rhodesia during the first indigenous rebellion of 1896 
(Gelfand, 1976). Both missionaries and settlers considered that antibiotics would open the 
door to Western ways of behaviour and smooth the ‘civilisation process’ that, amongst 
other things, would deter people from ‘evil’ practices of witchcraft and ‘charlatanism’(Iliffe, 
1998).
Despite all this, we should not forget that situations tend not to be as straightforward as 
they can appear in institutional documents or scientific papers: there were often contra-
dictory motives driven by the fact that the doctors were both health professionals and co-
lonisers at the same time (Fanon, 1994). Maintaining the health of African populations was 
an important part of the colonial agenda because of the colonial interest in legitimisation, 
productivity and safety of the white minorities, but it was also a commitment by itself. Just 
as in Western countries, antibiotics represented the battle against infectious disease, the 
major antagonist of humankind (Ranger and Slack, 1995) – and the opportunity to develop 
new ‘weapons’ against it. 
DISCUSSION
Mutizwa-Mangiza (1996) explains this mix 
in her history of the Zimbabwean health 
system: “in reality colonial healthcare was a 
tension between broader colonial ambitions 
and the routine interests of the different 
stakeholders involved in the delivery and 
consumption of healthcare services”. Colo-
nial doctors had to adapt to a new cultural 
environment through pseudo-ethnographic 
techniques and a constant reliance on their 
mission of civilisation, perceiving themsel-
ves as ‘saviours’ in a wild, dark world (Muti-
zwa-Mangiza, 1996). 
Non-human antibiotic uses (and non-uses) 
also point directly to the political agendas 
lying behind the colonisation process. As 
we have seen in previous sections, when 
looking at animal health the colonial 
imperatives of productivity and economic 
growth become even more evident – as 
productivity itself is regarded as a benefit 
in itself, not needing any sort of moral 
justification. The formulation of veterinary 
and agricultural policies, then, is heavily 
influenced by the capitalist orientation 
of Western economies, who brought it to 






Some difficulties the British Empire had finding a balance between legitimacy and pro-
ductivity in the provision of healthcare have been mentioned in section 1.2, as economic 
constraints limited the ability to provide a proper health service for whole populations. 
Probably the best way of explaining the colonial struggles for productivity is by illustrating 
it through the case of Southern Rhodesia in the middle of the century. Hodge (2007) des-
cribes how, during the 1940s, the Southern Rhodesian government concluded that local 
resource management was not guaranteeing proper colonial living standards – even for 
the white settler population. If those standards were to improve, the use of these resour-
ces needed to be more efficient, and consumer demand would need to be raised “since 
Britain was in no position (despite the rhetoric of the CD&W Acts) to finance the social 
services and other non-productive works such as erosion control that the empire so des-
perately needed”. 
In this context, we could say that the lack of resources influenced the use of antibiotics in 
both humans and non-humans, as we can see by the constant mentions of money-saving 
initiatives in governmental reports and plans. As an example, looking into the internatio-
nal concerns about syphilis gives insights about the interrelation between economy and 
medicine. In March 1952, the American Journal of Public Health published an extensive 
article about the incidence of syphilis in countries other than the United States or Western 
Europe. In this article, the concerns about the loss of productivity dominate the narrative: 
“In Northern Rhodesia it has been estimated that 100,000 man-days of labor are lost each 
year as a result of venereal disease” (Meleney, 1952).
Commercial agriculture
Commercial agriculture was a crucial part of the colonial agenda 
of the British Empire. Attempts to raise productivity and stimulate 
economic development were constantly part of government re-
ports and plans in the three focus countries – and, as Brown and 
Gilfoyle (2010) put it, “veterinary medicine was by no means for the 
benefit of all”, but was skewed towards the colonial agenda.
This is particularly clear in the case of the Federation of Rhodesia 
and Nyasaland. The Federation was formed with the clear objective 
of ‘unifying forces’ and creating a powerful African state (Keatley, 
1963). This model was influenced largely by South Africa, to such 
an extent that the Federation implemented “Co-Operative Move-
ment” (through the ‘Co-Operative Companies Act’), entering into 




One of the ways of proving the proper functioning and solidity 
of this state was through the use of new technologies to achieve 
economic growth. The Annual Report to the Ministry of Agricultu-
re of 1954 starts by congratulating the Federation, who produced 
the report, on the increased production and points out that this 
this is not “due to Nature only” but is the result of “better farming 
systems and scientific practices”. The main idea of the report is that 
the maintenance – and increase – of the levels of production can 
only be achieved by the application of these “scientific practices” 
to all the farming systems of the country. Similarly, a US-produced 
and -directed manual for investing in the Federation (Weeks and 
Macy, 1956) also highlights this economic growth, and attributes it 
to the “slowly growing realization” that problems cannot be sol-
ved without “the aid of science and technology”. The Federation is 
pictured as having placed a growing emphasis on productivity by 
investing in more economic farming units and “heavier capitaliza-
tion”. 
However, despite all this propaganda and promises, the Federation did not last enough 
to prove the success of their initiatives, and there is evidence of some less-than harmo-
nic – and effective – development of commercial agriculture in those countries (Bolt and 
Green, 2015; Duggan, 1980; Kalinga, 1993; Keatley, 1963). 
Likewise, elsewhere in East Africa it was common to find a “lack of development of 
commercial livestock production” (Brown and Gilfoyle, 2010), which was largely attribu-
ted to the inability and unwillingness of the native population to ‘adapt’, ‘learn’ or even 
‘obey’ the prerogatives of development and modern agriculture. This view is shown by 
an exchange of letters between the Director of Veterinary Services in Uganda and the 
Chief Secretary (during 1929-30) (Perryman, 1929) about the administration of the Soroti 
stock farm – one of the ‘stock farms’ that demonstrated how to farm commercially and 
supplied breeding material for the ‘progressive farmers’ already mentioned. In the mail 
exchange, it is matter of debate whether the farm should remain under native adminis-
tration or if the protectorate should take over; the conclusion is that, as native manage-
ment is less effective, it would be more profitable for the government to take control.
This tendency to mistrust native agricultural systems and label them as incorrect or 
‘irrational’ can be also seen in a ‘Review of Nutrition’ that was carried out by the Medical 
Department of Uganda in 1949 (Uganda Medical Department, 1949): production of lives-
tock is declared ‘problematic’ due to the over-consumption of supplies, tsetse and “the 
relative neglect of animal husbandry”. To overcome this, it is suggested that the Veteri-
nary Department intervene in the conservation of livestock by taking measures such as 
the suppression and control of epizootic disease, the “steady development of the market 
system”, the active encouragement of pig breeding, the supervision of native dairying or 




More modern and nuanced accounts offer alternative explanations for this failure. For 
example, Bolt and Green (2015) suggest, talking about Nyasaland, that domestic colo-
nial policies played a limited role, and that colonial economic measures should be better 
understood in the context of regional mobility of workforce and global markets – which, 
ultimately, determined the value of the output. They state that, since Nyasaland was one 
of the poorest colonies in Africa, “to assume that the colonial authorities had the capacity 
to direct developments in a desired direction given these circumstances makes little sen-
se” – colonies had to adapt to the global circumstances, and that adaptation depended 
on circumstantial factors such as the strength of colonial authority, ecological conditions 
and socio-political developments.
These conditions also determined the convenience or inconvenience of using antibiotics 
as part of those attempts at technological farming and ‘development’. The South African 
examples already mentioned are useful for illustrating this fact – even in the wealthiest 
part of colonial Africa, antibiotics were rejected because of their price (Kruger, 1959, 
1960a, 1960b). On other occasions, their use was considered ‘unnecessary’ if there was 
proper nutrition – as was the conclusion of the study looking into the effects of including 
‘Aurofac’ in pig rations (Pieterse and Verbeek, 1958).
DISCUSSION
It appears that the factor that most influenced the use of antibio-
tics in African livestock production was the import of exotic breeds 
for commercial purposes. As Interviewee #2, the vet from Uganda, 
puts it, local breeds could grow up without needing any kind of 
treatment or prophylaxis. However, exotic animals were not resi-
lient to the local climate, parasites and other diseases, and so had 
a greater need of medical care. Additionally, exotic breeds required 
a greater investment, as their purchase was more expensive for 
the farmers, so farmers “will try all advice given to sustain the ani-
mal’s life”. Therefore, the rise of commercial production influenced 
greatly the use of antibiotics.
Regarding the inclusion of antibiotics in feeds, Interviewee #2 
describes them as a late addition, mostly driven by the same will of 
‘securing’ the investment carried out when purchasing the animals. 
The so-called ‘medicated feeds’ worked as an ‘insurance’, guaran-
teeing both that the feed was free of bacterial infection and that it 
would act as a ‘soft’ prophylaxis against bacterial disease. So, we 
can infer from this that the use of these feeds was also related to 





Finally, it is important to add a brief comment on how the trade of antibiotics brings to 
light their materiality and their construction as commodities that have a market value  
– a value that can be seen apart from their therapeutic properties. 
The conceptualisation and formation of antibiotics as commodities has been detailed by 
Bud (2007), who talks about how penicillin was considered a ‘tool’ “prudent for patients’ 
health and useful in the practical business of medicine”. During the early twentieth cen-
tury, preventive healthcare was complemented by a new pharmaceutical model of treat-
ment driven by consumers, industry and science. This was the beginning of the dynamic 
of treating medicines as consumer goods, with a mix of traditional medicines supple-
mented by commercial ones (Bud, 2007). It is also important to note the growth of ‘ethical 
pharmacy’, with its claims for an evidence-based development of new drugs, advocating 
for a ‘scientific’ model of production. When we reached the middle of the century, the mo-
dern pharmaceutical industry was perceived as powerful and effective thanks to a mixture 
of good marketing and science-based trust.
This highlights the insertion of drugs into a sphere beyond medical practice: the marke-
ting and business sphere. Bud discusses at length the implications of this ‘brandification’ 
of penicillin for its broader use: when we contemplate penicillin use through the ‘logic 
of the brand’ (as opposed to the logic of the chemical, which would be the one used by 
doctors and medical authorities concerned about misuse and resistance), certain patterns 
of consumption that were labelled as ‘irrational’ become rational and logical. Media stu-
dies scholars have analysed brands as being more than a label for a product; as material 
semiotics, these labels carry a set of expectations, hope, personal experiences and reputa-
tion – therefore, we could state that constructing penicillin as a brand made it reliable and 
trustworthy by default, while doctors still needed to prove themselves valid to patients. 
Following this, thinking of antibiotics as commodities allows us to consider their existence 
outside the medical community – and, as such, outside the control and authority exer-
ted by the Western practice of biomedicine. This, of course, has some dangers related to 
misinformation and mercantile interest promoting consumption – leading to problems like 
resistance or accessibility. But this also explains how, in societies like those of colonial Afri-
ca, where the medical community could not exert a great deal of control, the use of drugs 
was not necessarily attached to Western medicine – and antibiotics became assimilated by 
cultures used to dealing with new medicines (Bud, 2007). 
Santesmases and Gradmann (2011) have studied the circulation of antibiotics around 
global settings – ‘circulation’ implying a transit between countries, not so much circular as 
a fluid movement with many different ends. In their conceptualisation, they make refe-
rence to ‘permanent feedback’ taking place between the actors and spaces involved in the 
history of antibiotics – this relates to the different flows that were carried by antibiotics. 
By circulating among different countries, antibiotics carried along a diversity of standards, 
contributing “to the rearrangement of antibiotic cultures and practices” (2011: 303).
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The history of antibiotics is intrinsically related to the history of patenting and industrial 
regulation (Santesmases and Gradmann, 2011). The development of antibiotics set in 
motion a process of ‘regularisation’ that culminated when, around the 1950s, standardi-
sed and ‘branded’ products displaced the individual prescriptions by dispensing chemists 
that had been the norm until then (Bud, 2007; Macfarlane and Worboys, 2008). Marketing 
became the main source of information about drugs for the general public, and, through 
this, antimicrobial drugs helped to consolidate the authority and power of the pharmaceu-
tical industry. 
In the colonial world, pharmaceuticals appear to have had an initially marginal role, but 
soon, as we have already discussed, they became important tools for the medicalisation of 
colonial empires (Monnais, 2009). Hence, following Monnais (2009) we can consider mo-
dern medicines as part of a colonial economy of health where the colonised subject beca-
me “a consumer of healthcare through practices of pharmaceutical consumption”, even 
though – as we also have mentioned before – colonial and health authorities were not 
always able to channel and direct this process. 
DISCUSSION
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Throughout this report, we have observed and analysed an extensive and exhaustive 
combination of archival research, literature and oral interviews. However, the process 
through which this kind of work is developed is always subject to a certain loss of infor-
mation: faced with obvious limitations of time, space and a necessary degree of legibility 
of the final product, the researcher must carry out some ‘classificatory practices’ – that 
is, grouping, generalising and deciding which examples to include. These practices are 
necessarily hierarchical, meaning that the researcher organises the facts by their relative 
importance, prioritising some over others – based on their own training and experience.
However, these categories are not absolute, but always subjected to change, contesta-
tion and negotiation, keeping the research ‘alive’ and becoming more and more nuan-
ced. In this project, we have been looking into the use of antibiotics from the 1940s to 
the 1960s in the three focus countries of Zimbabwe, Malawi and Uganda. But this is only 
the beginning; the next question is, what else might it be useful to do?
This research’s objective is to be an introductory account to the history of antibiotics in 
colonial Africa; now, the way is open for further research and alternative accounts to 
come. First, it would be important to ask what was happening on the rest of the conti-
nent; the socio-political context of French, German, Portuguese and Belgian colonies 
was often radically different from the context of the British Empire. Knowing more about 
the early uses of antibiotics in these territories could help us to understand how the-
se uses relate to different colonial administrations – each of them with their particular 
agendas and institutions.
Not less important would be to address what happened after the independence proces-
ses that most African colonies went through. The nature of these independences, the 
way in which they were carried out and the evolution of their resulting countries, varies 
immensely. Looking into how these fluctuations have affected the use of antibiotics in 
comparison to colonial times would provide important insights into the socio-political 
insertion of the drugs.
We have mentioned the international circulation of antibiotics and the flows that are ge-
nerated through this; another point that calls for further research would be looking into 
how these international flows evolved. Especially important for this would be the investi-
gation of the changes that the arrival of generics brought along, and the role played by 
Asian markets (such as China and India). 
And, of course, more questions could be asked – what was the exact role of private 
markets, and how is this history interconnected with international movements (such as 
‘essential medicines’, rational use, stewardship, One Health, etc.)? In this report, we have 
carried out a first effort that we hope will begin a long and fruitful series of contributions 
to the topic of the history of medicines – a topic that, as relevant as it is, has not yet been 
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For much of its existence, the British Empire can be characterised as having central concer-
ns of control and legitimacy. The aim was to create a solid, centralised and stable system 
that was profitable or, at the very least, self-sufficient, but the lack of resources and human 
capital challenged this project. In the next sections we will dig into the particular elements 
and the intersections between control, economy and legitimacy.
Many colonial initiatives can be read as attempts to achieve this homogenisation; for 
example, in 1947 there appeared in The Lancet an article about the ‘Empire Reciprocity in 
Social Insurance’(‘Empire Reciprocity in Social Insurance’, 1947). In this article, the prepa-
ratory training of medical officials from an array of countries (including Southern Rhode-
sia) is described in order to set the bases of ‘reciprocity in the field of social insurance’ – 
that is, the aim of keeping a constant exchange of professionals and resources from and 
to the colonies. 
The main tool for this was the regulation of medical practice by the obligatory register 
of all medical practitioners – national and foreign. These regulations were aimed at, first, 
creating a standard of quality of medical service – not only in the public health service, 
but also in private practice – and, second, consolidating the position of the government 
as the authority that controlled, not only how healthcare was delivered, but also who was 
able to deliver it. In the British Medical Journal (‘Registration Of Foreign Practitioners In 
Great Britain And The Dominions And Colonies’, 1937), we find a roster of the requisi-
tes for foreign practices that wanted to set up a private consulting room (see the table 
below).
CONTROL
Nyasaland Accepted everyone with a British, British Indian or British Colonial degree (also Europe, US and Japan).
Southern Rhodesia Accepted if completed five year’s training within the British Empire.
Uganda
“Any person registered in the UK is eligible for 
registration in Uganda, but the prospects of private 
practice are very limited”.
As we can see, rules and requisites differ within territories, depending on the local 
interests and the availability of medical positions. These regulations also provide a 
good insight into the conditions of each focus country: the rules are stricter in Southern 
Rhodesia (now Zimbabwe) than in the other two countries, given its status as self-
governing colony. Also, even though in the UK Government notice No.942 of 1948 it 
is stated that medical practitioners registered in the UK can also register in “British 
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colonies, protectorates and dependencies where the rules are identical with those of 
the UK”, Southern Rhodesia had its own rules for registration (‘Medical Practitioners in 
Southern Rhodesia’, 1956). This differentiation allows us to grasp how the reality of the 
colonies was very different from the theory of a strong, London-dependent empire.
Moreover, the difficulties and delays in communications and the lack of staff meant that 
bureaucracy was more an obstacle than a help to the smooth functioning of the CMS. A 
memorandum on medical policy by the Ugandan colonial government in 1943  (Medical 
Policy, 1943) argued that some improvements should be made in the structure of the 
colonial service in order to “deviate the Secretariat bottleneck”. It also criticised the 
homogenisation of the colonial administration, stating that “it is wrong to put a standard 
pattern for all the Colonies”. As we can see, given the difficulties of exerting rigid external 
control over the colonies, health policies were often designed and implemented without 
the British government’s permission – or even knowledge (Hokkanen, 2016). 
Despite these difficulties, the CMS always tried to keep some sort of control over the 
native populations, and one of the main ways of doing this was the direct intervention by 
training native staff. Holden (2015) describes how training of local staff was an accepted 
part of nurses’ work – initially, it was carried out by missionaries but, from 1940s on, 
governments undertook this task, trying to systematise it. This was, in part, responding 
to the necessity of human resources in healthcare, but it was also considered part of 
the ‘civilisation’ mission of the Empire: educating Africans in Western medical practices 
would bring them closer to the ‘rationality’ of European thought, and would help in its 
expansion (Digby and Sweet, 2002). 
Indeed, the figure of the nurse had an important role in solving the clash between local 
traditional health systems, where nursing was regarded as part of a kinship relationship, 
and the Western disease-based care system (Kuper, 1965; seen in Holden, 2015). In 
a monograph on this topic, Welch (1941) described the “future challenges” regarding 
the training of African nurses, which ranged from the necessity of “separat[ing] native 
nurses from ideas of ‘magic’” in order to “help their patients to do so”, to “find[ing] ‘better 
quality’ girls” who should be separated from their home backgrounds in order to become 
‘good nurses’. Welch also highlighted the ‘educational’ role of the nurse, as preventive 
medicine requires a professional who is both nurse and educator – the idea was that the 
nurses should supply all these services to families, acting as a family friend.
ANNEX 1: HISTORY OF THE COLONIAL MEDICAL SERVICE
71ANNEX 1: HISTORY OF THE COLONIAL MEDICAL SERVICE
Despite all the colonial authorities’ efforts, we have seen that the imperial dream of a 
solid and centralised management remained just a dream. This was, to a large extent, 
due to the obligation of self-sufficiency and economic tightness that characterised the 
imperial project since its very beginning. It has been said that the financial limitations 
that played a role in the underdevelopment of health services in African settings should 
be viewed “more in terms of colonial priorities than simply the lack of funds” (Chikumbu, 
n.d.). Although this is likely to be the case, the simple fact is that, whatever the reasons, 
there was a lack of funds – which definitely affected the shape of the CMS. 
However, the CMS’s priorities clearly favoured white settlers over African populations. 
This can be observed in the description that The Lancet made of, on one hand, the health 
system of Southern Rhodesia, and, on the other hand, the medical practice in East Africa 
(Davidson, 1954): the hospitals in Rhodesia were built, owned and administered by the 
Rhodesian government. The largest European hospitals in Salisbury and Bulawayo are 
described as “well constructed and excellently equipped”, probably related to the fact 
that European patients were asked to pay their hospital fees. African patients were loca-
ted in separate hospitals that were “antiquated and overcrowded”, with staff drawn from 
the Rhodesian Medical Service. There was the option of private practice for Europeans, 
with a lot of competition among the practitioners. 
The medical practice in ‘East Africa’ (which, in this context, meant Kenya, Tanganyika and 
Uganda) was heavily influenced by the scarce European population – which, the article 
says, did not offer many opportunities for private practice. The CMS there is described 
as “barely having any resources”, which rendered it more difficult to provide Western 
medicine for even a minority of the African population. To tackle this problem, the CMS 
announced increased training of African staff in Makerere University and the construc-
tion of a medical school at Kampala (Uganda). Additionally, penicillin, sulphonamides and 
‘new synthetic drugs’ are portrayed as playing an essential role in “convincing Africans 
that Western medicine is an improvement on the medicine of the witch-doctor”. 
Nonetheless, getting enough of the ‘Western medicines’ was also hampered by the lack 
of resources: in a description that Goodall (1955) made about the treatment of tubercu-
losis in Zomba African Hospital (in Nyasaland), he noticed the lack of proper facilities to 
treat the disease – as Nyasaland was a poor agricultural country, treatment was delive-
red depending on what was available. Little money could be spared, so cheaper drugs 
were preferred – it was not possible to treat patients “following the ‘expert’ recommen-
dations from the UK and the US”. Relatedly, in the ‘Tubercle’ journal it is stated that “an 
effective and cheap combination of antituberculosis drugs would thus be of outstanding 
value in the control of tuberculosis in Africa” (‘A Co-operative investigation in East African 
Hospitals and Laboratories’, 1959). These limitations continued through time; even as 
late as 1972, it is possible to find a letter from the Secretary of the Ministry of Health of 
Uganda mentioning restrictions in antibiotics supply in Tororo Hospital (Mapusl, 1972).
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LEGITIMACY AND ECONOMY
Another important concern for the British Empire concerned the legitimacy of the impe-
rial project itself. For this reason, the CMS was praised as one of the greatest institutions 
that the Europeans had brought to the colonies. Western medicine was regarded as the 
best, most reliable and most effective medicine, and was a vital tool to achieve progress, 
essential in a modern society. In The Lancet (Keir, 1954), we find an article called ‘Western 
medicine in the modern world’, in which is detailed the ‘goodness’ that colonial medical 
services had brought to the ‘uncivilised’ rest of the world. 
Nonetheless, as we have discussed in the main report, the lack of resources hampered 
the availability of Western medicine for most African populations. The arrival of antibio-
tics seemed a promising solution for this issue, because, as Hutton et al. (1956) said: “it 
was important to know how far, if at all, in a poor country chemotherapy could obviate 
the need for the costly organization which has been built up in Europe to deal with the 
disease”. Hutton et al. refer here to the necessary infrastructure for some treatments, 
such as bed therapy, collapse therapy or major surgery. Therefore, antimicrobial drugs 
were regarded as an alternative for this lack of resources. Additionally, these trials were 
considered to be a unique opportunity to test chemotherapy alone – without the influen-
ce of other treatments – which made the colonies ‘test labs’ for cheaper drugs and treat-
ments (Fox et al., 1956). 
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Looking at the case of Zimbabwe, we can observe to what extent the government relied 
on missionary healthcare to provide healthcare to rural Africans: even though, as we 
mentioned previously, the Southern Rhodesian government was obliged to set up some 
sort of health services by the 1925 Act, they solved the situation by giving missionaries an 
annual grant so they could provide these services in the rural areas. It was not until the 
1930s that the government expanded the health system to reach rural settings and, even 
then, missionaries remained the major provider (Mutizwa-Mangiza, 1996).
The missionary health service has been described as ‘curative-oriented’, in contrast with 
the preventive focus of the governmental medical services. Some authors have attributed 
this individual focus to the mission’s interest in using medicine as a ‘tool for evangelisation’ 
– which, on occasions, would have affected the quality of the service provided, justifying 
an uneven, second-rate care with the “spiritual benefits of the healing” (Doyle et al., 2020; 
C. M. Good, 2004). However, there is evidence of missionary hospitals that were not only 
considered good by mission standards, but were also highly thought of among colonial 
officers – such is the case, for example, of Mengo Hospital, in Uganda, which was constantly 
accepting patients (mostly white, but also a number of African and Indian) referred by 
colonial medical services across the country (Pringle, 2019).
Moreover, as Doyle et al. (2020) describe, also in Uganda, even though conversion was 
always an explicit aim in medical missions, it is undeniable that missionaries pioneered 
the provision of certain health services that targeted disadvantaged groups (such as for 
those with physical impairments, leprosy and other similar ailments). Additionally, they put 
a great deal of effort and interest into child and maternal healthcare (Doyle et al., 2020; 
Pringle, 2019; Stirling, 1947). One example of this can be seen in the Central African Medical 
Journal’s portrayal of medical work at Nyadiri Mission (in the Federation of Rhodesia and 
Nyasaland) (Dabb, 1956): the mission is described as “very concerned with maternity 
issues”, and most of their work revolves around the great incidence of preventable diseases 
in this field – the writer highlights the importance of educating mothers in sanitation, as the 
failure to comply with hygienic measures is regarded as the main cause of disease.
The same happened in Nyasaland in Blantyre Mission (Dabb, 1956), which stressed the 
importance of maternity care and took pride in their maternity ward, and in the Bonda 
Mission Hospital (also in Nyasaland), where, apart from the usual treatment facilities – and 
chapels, to care for the ‘spiritual health’ of the patients – they constructed a tuberculosis 
ward to cope with this problem. 
Even though evangelisation was not always successful, missionaries were, in general, fairly 
well accepted in rural African societies (Dube et al., 2009). It has been said that one of the 
keys of the lasting success of missionary medicine is rooted in African understandings 
of illness and healing, as more a ‘personal’ matter than a ‘professional’ one. Dube (2009) 
describes how, in Zimbabwe, missionaries visited the sick in their homes and provided 
outpatient services for those patients going to their hospitals and dispensaries. 
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Medical missions did not escape the lack of resources that the governmental medical 
services were facing, so they started training African staff from the beginning of the 
twentieth century. In Malawi, Vaughan describes how this African medical staff was almost 
exclusively male up to the 1930s (the so-called ‘dawa’ or ‘dispensary boys’). They often 
occupied positions of high responsibility, given the lack of European doctors (who were 
always prioritised).
Training of African health staff was also carried out as a strategy to “put the witchdoctor 
out of business”, as stated by one of the pioneers in the training of African nurses, Dr. 
McCord, in 1932 (Digby and Sweet, 2002). The main idea was that African health assistants 
could carry out basic tasks and go to the most remote regions to ‘fight’ traditional medicine 
and beliefs (Pringle, 2019) – but, in practice, this was far more ambiguous and a source of 
constant struggle.
In fact, it is not clear to what extent Christian conversion and mission education affected 
African health behaviour (Doyle et al., 2020): some evidence suggests that secular public-
health campaigns influenced people’s behaviour regardless of their religion or education. 
The nature of these changes, however, was not always aligned with colonial or missionary 
agendas. 
Although they were part of the colonial system, missionaries’ interests and perspectives 
were not necessarily the same as those of secular colonial institutions. For example, 
Vaughan (1991) describes the opposition of missionaries to the system of ‘customary’ 
and ‘traditional’ rule – while colonial governments were looking for the efficiency of the 
system of ‘indirect rule’, missionary agendas were directed to bringing ‘enlightenment’, 
‘progress’ and ‘civilisation’, gaining the populations’ souls for the Christian cause. Therefore, 
missionaries promoted social engineering, Western-type education and Christian 
evangelisation (Vaughan, 1991).
Missionaries were in close contact with local populations for a long while, which placed 
them in a position of mediation between the colonial state and African societies (Hokkanen, 
2016). Although always under their own terms, missionaries often had the role of 
translating knowledges and practices between the two worlds, informing the colonial 
administration about people’s health conditions, and assessing their improvement. This 
put the missions in an influential position, as they were able to participate in the decision-
making of the healthcare system.
The importance of the medical missions decreased towards the middle of the century; 
healthcare was taken over by colonial governments which, apart from making healthcare 
free, also started to provide free medical training for Africans – while missionaries had to 
stick with their fees, as their funding was not enough to maintain the healthcare system 
by itself (Messac, 2014; Vaughan, 1991). This meant a drastic change in the content of 
missionary work, even though the discourse remained the same (Vaughan, 1991).
Designed by Andrea Palanco
